<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Oral contraceptives for pain associated with endometriosis - Brown, J - 2018 | Cochrane Library</title> <meta content="Oral contraceptives for pain associated with endometriosis - Brown, J - 2018 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001019.pub3/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Oral contraceptives for pain associated with endometriosis - Brown, J - 2018 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001019.pub3/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD001019.pub3" name="dc.identifier" scheme="DOI"/> <meta content="Oral contraceptives for pain associated with endometriosis" name="citation_title"/> <meta content="Julie Brown" name="citation_author"/> <meta content="The University of Auckland" name="citation_author_institution"/> <meta content="juliebrown571@gmail.com" name="citation_author_email"/> <meta content="Tineke J Crawford" name="citation_author"/> <meta content="The University of Auckland" name="citation_author_institution"/> <meta content="Shree Datta" name="citation_author"/> <meta content="King's College Hospital NHS Foundation Trust" name="citation_author_institution"/> <meta content="Andrew Prentice" name="citation_author"/> <meta content="University of Cambridge Clinical School" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="5" name="citation_issue"/> <meta content="10.1002/14651858.CD001019.pub3" name="citation_doi"/> <meta content="2018" name="citation_date"/> <meta content="2018/05/22" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001019.pub3/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001019.pub3/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001019.pub3/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Contraceptives, Oral [*therapeutic use]; Dysmenorrhea [*drug therapy]; Endometriosis [complications, *drug therapy]; Goserelin [therapeutic use]; Pelvic Pain [*drug therapy, etiology]; Randomized Controlled Trials as Topic" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001019.pub3&amp;doi=10.1002/14651858.CD001019.pub3&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001019.pub3&amp;doi=10.1002/14651858.CD001019.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001019.pub3&amp;doi=10.1002/14651858.CD001019.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001019.pub3&amp;doi=10.1002/14651858.CD001019.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001019.pub3&amp;doi=10.1002/14651858.CD001019.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001019.pub3&amp;doi=10.1002/14651858.CD001019.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001019.pub3&amp;doi=10.1002/14651858.CD001019.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001019.pub3&amp;doi=10.1002/14651858.CD001019.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001019.pub3&amp;doi=10.1002/14651858.CD001019.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001019.pub3&amp;doi=10.1002/14651858.CD001019.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001019.pub3&amp;doi=10.1002/14651858.CD001019.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001019.pub3&amp;doi=10.1002/14651858.CD001019.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001019.pub3&amp;doi=10.1002/14651858.CD001019.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001019.pub3&amp;doi=10.1002/14651858.CD001019.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001019.pub3&amp;doi=10.1002/14651858.CD001019.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001019.pub3&amp;doi=10.1002/14651858.CD001019.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001019.pub3&amp;doi=10.1002/14651858.CD001019.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001019.pub3&amp;doi=10.1002/14651858.CD001019.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001019.pub3&amp;doi=10.1002/14651858.CD001019.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001019.pub3&amp;doi=10.1002/14651858.CD001019.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001019.pub3&amp;doi=10.1002/14651858.CD001019.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001019.pub3&amp;doi=10.1002/14651858.CD001019.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001019.pub3&amp;doi=10.1002/14651858.CD001019.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774054000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774081000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000"}};Liferay.authToken="loVWuZlx";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD001019\x2epub3\x26doi\x3d10\x2e1002\x2f14651858\x2eCD001019\x2epub3\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001019\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD001019\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1559916434000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANS","ru","th","ja","pl","fr","ro","ms","fa","zh_HANT"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD001019.pub3",title:"Oral contraceptives for pain associated with endometriosis",firstPublishedDate:"May 22, 2018 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Gynaecology and Fertility Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738735355000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=loVWuZlx&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD001019.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD001019.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD001019.pub3/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD001019.pub3/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD001019.pub3%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD001019.PUB3" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;บทคัดย่อ&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;Abstract&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym językiem&quot;},{&quot;language&quot;:&quot;ro&quot;,&quot;title&quot;:&quot;Sumar&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;ข้้อสรุปภาษาธรรมดา&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;淺顯易懂的口語結論&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD001019.pub3/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD001019.PUB3" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD001019.pub3/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD001019.pub3/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>14761 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD001019.pub3" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001019.pub3/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001019.pub3/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001019.pub3/full#CD001019-abs-0006"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001019.pub3/full#CD001019-sec-0137"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001019.pub3/full#CD001019-sec-0043"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001019.pub3/full#CD001019-sec-0044"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001019.pub3/full#CD001019-sec-0049"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001019.pub3/full#CD001019-sec-0050"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001019.pub3/full#CD001019-sec-0073"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001019.pub3/full#CD001019-sec-0131"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001019.pub3/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001019.pub3/appendices#CD001019-sec-0142"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001019.pub3/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001019.pub3/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD001019.pub3/media/CDSR/CD001019/table_n/CD001019StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD001019.pub3/media/CDSR/CD001019/table_n/CD001019StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001019.pub3/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001019.pub3/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001019.pub3/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD001019.pub3/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD001019.pub3/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD001019.pub3/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2018 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Oral contraceptives for pain associated with endometriosis</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD001019.pub3/information#CD001019-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Julie Brown</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD001019.pub3/information#CD001019-cr-0003">Tineke J Crawford</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD001019.pub3/information#CD001019-cr-0004">Shree Datta</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD001019.pub3/information#CD001019-cr-0005">Andrew Prentice</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/information/en#CD001019-sec-0153">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 22 May 2018 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD001019.pub3">https://doi.org/10.1002/14651858.CD001019.pub3</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD001019-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD001019-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD001019-abs-0005">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD001019-abs-0016">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD001019-abs-0004">Français</a> </li> <li class="section-language"> <a class="" href="full/th#CD001019-abs-0003">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD001019-abs-0002">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD001019-abs-0001" lang="en"> <section id="CD001019-sec-0001"> <h3 class="title" id="CD001019-sec-0001">Background</h3> <p>Endometriosis is a common gynaecological condition which affects many women of reproductive age worldwide and is a major cause of pain and infertility. The combined oral contraceptive pill (COCP) is widely used to treat pain occurring as a result of endometriosis, although the evidence for its efficacy is limited. </p> </section> <section id="CD001019-sec-0002"> <h3 class="title" id="CD001019-sec-0002">Objectives</h3> <p>To determine the effectiveness, safety and cost‐effectiveness of oral contraceptive preparations in the treatment of painful symptoms ascribed to the diagnosis of laparoscopically proven endometriosis. </p> </section> <section id="CD001019-sec-0003"> <h3 class="title" id="CD001019-sec-0003">Search methods</h3> <p>We searched the following from inception to 19 October 2017: the Cochrane Gynaecology and Fertility Group Specialised Register of Controlled Trials, the Cochrane CENTRAL Register of Studies Online (CRSO), MEDLINE, Embase, PsycINFO, CINAHL (Cumulative Index to Nursing and Allied Health Literature), and the trial registers ClinicalTrials.gov and the World Health Organization Clinical Trials Registry Platform (WHO ICTRP). We also handsearched reference lists of relevant trials and systematic reviews retrieved by the search. </p> </section> <section id="CD001019-sec-0004"> <h3 class="title" id="CD001019-sec-0004">Selection criteria</h3> <p>We included randomised controlled trials (RCT) of the use of COCPs in the treatment of women of reproductive age with symptoms ascribed to the diagnosis of endometriosis that had been made visually at a surgical procedure. </p> </section> <section id="CD001019-sec-0005"> <h3 class="title" id="CD001019-sec-0005">Data collection and analysis</h3> <p>Two review authors independently assessed study quality and extracted data. One review author was an expert in the content matter. We contacted study authors for additional information. The primary outcome was self‐reported pain (dysmenorrhoea) at the end of treatment. </p> </section> <section id="CD001019-sec-0006"> <h3 class="title" id="CD001019-sec-0006">Main results</h3> <p>Five trials (612 women) met the inclusion criteria. Only three trials (404 women) provided data that were suitable for analysis. </p> <p><b>Combined oral contraceptive pill versus placebo</b> </p> <p>Two trials compared COCP with a placebo. These studies were at high risk of bias. For GRADE outcomes (self‐reported pain (dysmenorrhoea) at the end of treatment), the quality of the evidence very low. Evidence was downgraded for imprecision as it was based on a single, small trial and for the visual analogue scale data there were wide confidence intervals (CIs). There appeared to have been substantial involvement of the pharmaceutical company funding the trials. </p> <p>Treatment with the COCP was associated with an improvement in self‐reported pain at the end of treatment as evidenced by a lower score on the Dysmenorrhoea verbal rating scale (scale 0 to 3) compared with placebo (mean difference (MD) ‐1.30 points, 95% CI ‐1.84 to ‐0.76; 1 RCT, 96 women; very low quality evidence), a lower score on the Dysmenorrhoea visual analogue scale (no details of scale) compared with placebo (MD ‐23.68 points, 95% CI ‐28.75 to ‐18.62, 2 RCTs, 327 women; very low quality evidence) and a reduction in menstrual pain from baseline to the end of treatment (MD 2.10 points, 95% CI 1.38 to 2.82; 1 RCT, 169 women; very low quality evidence). </p> <p><b>Combined oral contraceptive pill versus medical therapies</b> </p> <p>One underpowered trial compared the COCP with another medical treatment (goserelin). The study was at high risk of bias; the trial was unblinded and there was insufficient detail to judge allocation concealment and randomisation. For GRADE outcomes (self‐reported pain (dysmenorrhoea) at the end of treatment), the quality of the evidence ranged from low to very low. </p> <p>At the end of treatment, the women in the goserelin group were amenorrhoeic and therefore no comparisons could be made between the groups for the primary outcome. At six months' follow‐up, there was no clear evidence of a difference between women treated with the COCP and women treated with goserelin for measures of dysmenorrhoea on a visual analogue scale (scale 1 to 10) (MD ‐0.10, 95% CI ‐1.28 to 1.08; 1 RCT, 50 women; very low quality evidence) or a verbal rating scale (scale 0 to 3) (MD ‐0.10, 95% CI ‐0.99 to 0.79; 1 RCT, 50 women; very low quality evidence). At six months' follow‐up, there was no clear evidence of a difference between the COCP and goserelin groups for reporting complete absence of pain as measured by the visual analogue scale (risk ratio (RR) 0.36, 95% CI 0.02 to 8.43; 1 RCT, 50 women; very low quality evidence) or the verbal rating scale (RR 1.00, 95% CI 0.93 to 1.08; 1 RCT, 49 women; low quality evidence). </p> </section> <section id="CD001019-sec-0007"> <h3 class="title" id="CD001019-sec-0007">Authors' conclusions</h3> <p>Based on the limited evidence from two trials at high risk of bias and limited data for the prespecified outcomes for this review, there is insufficient evidence to make a judgement on the effectiveness of the COCP compared with placebo and the findings cannot be generalised. </p> <p>Based on the limited evidence from one small trial that was at high risk of bias, there is insufficient evidence to make a judgement on the effectiveness of the COCP compared with other medical treatments. Only one comparison was possible, with the medical intervention being goserelin, and the findings cannot be generalised. </p> <p>Further research is needed to fully evaluate the role of COCPs in managing pain‐related symptoms associated with endometriosis. There are other formulations of the combined hormonal contraception such as the transdermal patch, vaginal ring or combined injectable contraceptives which this review did not cover but should be considered in future updates. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD001019-abs-0006" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD001019-abs-0006">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD001019-abs-0013">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD001019-abs-0017">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD001019-abs-0012">Français</a> </li> <li class="section-language"> <a class="" href="full/ja#CD001019-abs-0010">日本語</a> </li> <li class="section-language"> <a class="" href="full/ms#CD001019-abs-0015">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pl#CD001019-abs-0011">Polski</a> </li> <li class="section-language"> <a class="" href="full/ro#CD001019-abs-0014">Română</a> </li> <li class="section-language"> <a class="" href="full/ru#CD001019-abs-0008">Русский</a> </li> <li class="section-language"> <a class="" href="full/th#CD001019-abs-0009">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD001019-abs-0007">简体中文</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD001019-abs-0018">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD001019-abs-0006" lang="en"> <h3>Modern combined oral contraceptives for treatment of pain associated with endometriosis</h3> <p><b>Review question</b> </p> <p>The combined oral contraceptive pill (COCP) is commonly used to treat pain associated with endometriosis but how well it works is unclear. </p> <p><b>Background</b> </p> <p>Endometriosis is a common women's healthcare condition where the endometrium (lining of the womb) grows at sites outside the womb, such as the ovaries (which produce eggs). Endometriosis is commonly found in women with painful periods, pain with sexual intercourse, pelvic pain and infertility (difficulty in having a baby). Hormonal treatments, including COCPs and medicines called gonadotrophin‐releasing hormone analogues (for example, goserelin) are used to relieve the pain symptoms associated with endometriosis. However, many of the hormonal treatments have side effects which limit their acceptability and duration of use. </p> <p><b>Study characteristics</b> </p> <p>Cochrane authors searched for clinical studies on 19 October 2017. We found five trials, including 612 women, that met the inclusion criteria. The studies took place in Egypt, the US, Japan and Italy. </p> <p><b>Key results</b> </p> <p>Only three of the included studies provided data in a format that could be analysed in this review. </p> <p><i>Combined oral contraceptive pill versus placebo</i> </p> <p>We found two trials including 354 women that compared the COCP with a placebo (pretend treatment). The evidence was at high risk of bias. There was very low quality evidence that treatment with the COCP was associated with an improvement in self‐reported dysmenorrhoea (period pain) at the end of treatment measure on a verbal rating scale (where the woman rates her pain as (for example) "no pain," "slight pain," "moderate pain," "severe pain" and "unbearable pain") and low quality evidence for an improvement in self‐reported dysmenorrhoea pain at the end of treatment using a visual rating scale (where the woman marks her pain visually on a line) compared with placebo. There was very low quality evidence that there was a reduction in menstrual pain from the beginning to the end of treatment in the COCP group compared with women having a placebo. </p> <p><i>Combined oral contraceptive pill versus other medical treatment</i> </p> <p>We found one trial of 50 women that compared the COCP with another medical treatment (goserelin). </p> <p>The study was at high risk of bias. At the end of treatment, the women in the goserelin group were not having a period and therefore we could not compare the groups. </p> <p>Six months after the end of treatment, there was very low quality evidence that there was no clear difference between women treated with the COCP and women treated with goserelin for self‐reported dysmenorrhoea, using a visual rating scale or a verbal rating scale. Six months after the end of treatment, there was very low quality evidence that there was no clear evidence of a difference between the COCP and goserelin groups for reporting complete absence of pain, as measured by a visual rating scale and low quality evidence using a verbal rating scale. </p> <p><b>Quality of the evidence</b> </p> <p>The quality of the evidence was very low quality. The main reasons for downgrading the evidence were because the data were based on a single small trial with wide variation in results and lack of details about how the study had been designed. There were some concerns with two of the studies that were funded by a pharmaceutical company that also had input into the design of the trial, data collection and the analysis of data. This means that we cannot be confident about the results. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD001019-sec-0137" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD001019-sec-0137"></div> <h3 class="title" id="CD001019-sec-0138">Implications for practice</h3> <section id="CD001019-sec-0138"> <p>Based on the limited evidence from two trials and limited data for the prespecified outcomes for this review, there is insufficient evidence to make a judgement on the effectiveness of the combined oral contraceptive pill (COCP) compared with placebo. </p> <p>Based on the limited evidence from one small trial that was at high risk of bias, there is insufficient evidence to make a judgement on the effectiveness of COCP compared with other medical treatments. Only one comparison was possible, with the medical intervention being goserelin. </p> <p>Given the widespread and recommended use of the COCP in this setting, clinicians need to make decisions based on other available evidence. </p> </section> <h3 class="title" id="CD001019-sec-0139">Implications for research</h3> <section id="CD001019-sec-0139"> <p>Endometriosis is a common disease and the treatments currently available have unpleasant adverse effects. For all hormonal treatments other than COCP, the duration of therapy is limited, at least theoretically. It is well known that symptoms frequently recur when medication is stopped. If COCP could be shown to be at least as effective and safe as the existing well‐recognised therapies, it would offer a wider choice of treatment options, including long‐term symptom control. Acceptability from the perspective of the consumer should be considered when designing these studies. </p> <p>There continues to be a need for larger studies of oral contraceptive pill use for pain in endometriosis, accompanied by measures of participant satisfaction. However, the tendencies to treat endometriosis‐associated symptoms in the absence of a surgical diagnosis and surgically confirmed disease at the initial laparoscopy may make such studies difficult to perform and funding is likely to be problematical. Studies that compare COCP with other hormonal contraceptives, such as the levonorgestrel‐releasing intrauterine system, would be welcomed but it is more likely that these will be undertaken in the field of secondary prevention rather than primary treatment reflecting current clinical practice. </p> <p>We found no studies comparing COCP and conservative surgical treatment.</p> <p>Further research is needed to evaluate fully the role of oral contraceptive pills in managing pain‐related symptoms associated with endometriosis. There are other formulations of the combined hormonal contraception such as the transdermal patch, vaginal ring or combined injectable contraceptives that were not covered in this review but should be considered in future updates. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD001019-sec-0043" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD001019-sec-0043"></div> <div class="table" id="CD001019-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Combined oral contraceptive pill compared to placebo or no treatment for pain associated with endometriosis</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Combined oral contraceptive pill (COCP) compared to placebo/no treatment for pain associated with endometriosis</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> women with endometriosis<br/> <b>Setting:</b> Japan<br/> <b>Intervention:</b> COCP<br/> <b>Comparison:</b> placebo </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with placebo/no treatment</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with COCP</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Self‐reported pain (dysmenorrhoea) at the end of treatment: dysmenorrhoea VRS</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean self‐reported pain (dysmenorrhoea) at the end of treatment: Dysmenorrhoea VRS was 3.7 </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 1.3 lower<br/> (1.84 lower to 0.76 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>96<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>Very low</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>VRS ranged from 0 to 3.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Self‐reported pain (dysmenorrhoea) at the end of treatment: dysmenorrhoea VAS</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean self‐reported pain (dysmenorrhoea) at the end of treatment: Dysmenorrhoea VAS was 46.2 </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 23.68 lower<br/> (28.75 lower to 18.62 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>327<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>Very low</b><sup>2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No details provided for the VAS.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Self‐reported pain: menstrual pain reduction from baseline to end of treatment</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean menstrual pain (reduction from baseline to end of treatment) was 3.00</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>MD 2.10 lower (1.38 lower to 2.82 lower)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>169</p> <p>(1 RCT)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>Very low</b><sup>1,2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Used a VAS from 0 to 10 where 10 was extreme pain.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>COCP:</b> combined oral contraceptive pill; <b>MD:</b> mean difference; <b>RCT:</b> randomised controlled trial; <b>VAS:</b> visual analogue scale; <b>VRS:</b> verbal rating scale. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate quality:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low quality:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low quality:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Imprecision: evidence was based on a single small trial; downgraded one level. </p> <p><sup>2</sup>Risk of bias: trial judged to be at high risk of bias; downgraded two levels. </p> <p><sup>3</sup>Imprecision: evidence based on a single trial including 96 women; wide confidence intervals; downgraded two levels. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD001019-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Combined oral contraceptive pill compared to other medical treatment for pain associated with endometriosis</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Combined oral contraceptive pill (COCP) compared to other medical treatment for pain associated with endometriosis</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> women with endometriosis<br/> <b>Setting:</b> Italy<br/> <b>Intervention:</b> COCP<br/> <b>Comparison:</b> other medical treatment (goserelin) </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with other medical treatment</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with COCP</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Self‐reported pain (dysmenorrhoea) at the end of treatment (continuous data): dysmenorrhoea at 6 months' follow‐up: VAS</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean self‐reported pain (dysmenorrhoea) at the end of treatment (continuous data): dysmenorrhoea at 6 months' follow‐up was 7.5 </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 0.1 lower<br/> (1.28 lower to 1.08 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>Very low</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>VAS ranged from 1 to 10.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Self‐reported pain (dysmenorrhoea) at the end of treatment (continuous data): dysmenorrhoea at 6 months' follow‐up: VRS</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean self‐reported pain (dysmenorrhoea) at the end of treatment (continuous data): dysmenorrhoea at 6 months' follow‐up was 4.8 </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 0.1 lower<br/> (0.99 lower to 0.79 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>Very low</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>VRS ranged from 0 to 3.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Self‐reported pain (dysmenorrhoea) (dichotomous data): reduction of pain to zero at 6 months' follow‐up: VAS</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>38 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>14 per 1000<br/> (1 to 324) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.36<br/> (0.02 to 8.43) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>Very low</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>VAS ranged from 1 to 10.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Self‐reported pain (dysmenorrhoea) (dichotomous data) ‐ reduction of pain to zero at 6 months' follow‐up: VRS</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>1000 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>1000 per 1000<br/> (930 to 1000) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 1.00<br/> (0.93 to 1.08) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>49<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low</b><sup>1,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>VRS ranged from 0 to 3.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>COCP:</b> combined oral contraceptive pill; <b>MD:</b> mean difference; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio; <b>VAS:</b> visual analogue scale; <b>VRS:</b> verbal rating scale. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate quality:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low quality:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low quality:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Risk of bias: no blinding and randomisation and allocation concealment unclear; downgraded one level. </p> <p><sup>2</sup>Imprecision: evidence from a single small trial including 50 women; wide confidence intervals crossing the line of no effect; downgraded two levels. </p> <p><sup>3</sup>Imprecision: evidence from a single small trial reporting data on 49 women; downgraded one level. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD001019-sec-0044" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD001019-sec-0044"></div> <section id="CD001019-sec-0045"> <h3 class="title" id="CD001019-sec-0045">Description of the condition</h3> <p>Endometriosis is a common gynaecological condition which affects many women of reproductive age worldwide and is a major cause of pain and infertility (<a href="./references#CD001019-bbs2-0039" title="JacobsonTZ , BarlowDH , KoninkxPR , OliveD , FarquharC . Laparoscopic surgery for subfertility associated with endometriosis. Cochrane Database of Systematic Reviews2002, Issue 4. [DOI: 10.1002/14651858.CD001300] ">Jacobson 2002</a>). Symptomatic endometriosis most frequently causes pelvic pain. The pain may occur at the same as menstrual bleeding (dysmenorrhoea), during or after sexual intercourse (dyspareunia and post‐coital pain) or be present as other pelvic pain occurring in a cyclical or non‐cyclical pattern (<a href="./references#CD001019-bbs2-0036" title="FauconnierA , ChapronC . Endometriosis and pelvic pain: epidemiological evidence of the relationship and its implications. Human Reproduction Update2005;11(5):595‐606. ">Fauconnier 2005</a>). More rarely, endometriotic lesions may occur outside the pelvic region and these may also cause cyclical pain (<a href="./references#CD001019-bbs2-0045" title="LancasterJM , PrenticeA , SmithSK . Successful medical treatment of sub‐diaphragmatic endometriosis. Journal of Obstetrics and Gynaecology1995;15:206‐9. ">Lancaster 1995</a>). The prevalence of symptomatic endometriosis in the general population is difficult to estimate. One review of observational studies suggested that the prevalence of chronic pelvic pain ranged from 5.7% to 26.6% (<a href="./references#CD001019-bbs2-0028" title="AhangariA . Prevalence of chronic pelvic pain among women: an updated review. Pain Physician2014;17(2):E141‐7. ">Ahangari 2014</a>). Women who experience symptomatic endometriosis report significant reduction in their quality of life, with impact on many aspects of life (<a href="./references#CD001019-bbs2-0041" title="JonesG , JenkinsonC , KennedyS . The impact of endometriosis upon quality of life: a qualitative analysis. Journal of Psychosomatic Obstetrics and Gynaecology2004;25:123‐33. ">Jones 2004</a>). Endometriosis can also be found in asymptomatic women; for example, during a routine surgical procedure such as sterilisation. </p> <p>Endometriosis is defined histologically as the presence of endometrial glands or stroma in sites other than the uterine cavity, most commonly the peritoneum and ovaries. The main pathological processes associated with endometriosis are peritoneal inflammation and fibrosis, and the formation of adhesions and ovarian cysts. The aetiology of endometriosis remains unclear although there is now considerable evidence that it is a complex genetic trait (<a href="./references#CD001019-bbs2-0031" title="BarlowDH , KennedyS . Endometriosis: new genetic approaches and therapy. Annual Review of Medicine2005;56:345‐56. ">Barlow 2005</a>). Retrograde menstrual flow has long been accepted to be central to the development of endometriosis. This is unlikely to be an exclusive mechanism as retrograde menstrual flow is not limited to women who develop endometriosis (<a href="./references#CD001019-bbs2-0040" title="JohnsonN , FarquharC . Endometriosis. Clinical Evidence2006;15:2449‐64. ">Johnson 2006</a>), and retrograde menstruation does not explain the occurrence of endometriosis at all sites. It seems likely that in affected women, a genetic or immunologically linked susceptibility combines with retrograde menstruation to create endometriotic lesions in the pelvis (<a href="./references#CD001019-bbs2-0034" title="CrosignaniP , OliveD , BergqvistA , LucianoA . Advances in the management of endometriosis: an update for clinicians. Human Reproduction Update2006;12(2):179‐89. ">Crosignani 2006</a>). </p> </section> <section id="CD001019-sec-0046"> <h3 class="title" id="CD001019-sec-0046">Description of the intervention</h3> <p>Hormonal therapies aim to induce atrophy within the hormonally dependent ectopic endometrium. Definitive diagnosis is made by surgical inspection of the peritoneal cavity (<a href="./references#CD001019-bbs2-0042" title="Kennedy 2000 on behalf of the Guidelines and Audit committee of the Royal College of Obstetricians and Gynaecologist. The investigation and management of endometriosis 24. Royal College of Obstetricians and Gynaecologists: Green Top Guidelines2006. ">Kennedy 2006</a>). Treatment options include surgical removal of the abnormal tissue, symptomatic treatment, hormonal treatment or combinations of all three (<a href="./references#CD001019-bbs2-0048" title="YapC , FurnessS , FarquharC . Pre and post operative medical therapy for endometriosis surgery. Cochrane Database of Systematic Reviews2004, Issue 3. [DOI: 10.1002/14651858.CD003678.pub2] ">Yap 2004</a>). The aim of treatment, other than to reduce symptoms, has been to remove or decrease the activity of the deposits of ectopic endometrium that are thought to be responsible for the symptoms of endometriosis. This can be achieved surgically by destroying or removing the implants. Unfortunately, endometriosis tends to recur, both following surgery and when medication is stopped and may later develop into deep infiltrating endometriosis (endometrial deposits outside the uterus). </p> </section> <section id="CD001019-sec-0047"> <h3 class="title" id="CD001019-sec-0047">How the intervention might work</h3> <p>The clinical observation of apparent symptom resolution during pregnancy gave rise to the concept of treating women with a pseudopregnancy regimen (<a href="./references#CD001019-bbs2-0044" title="KistnerRW . Treatment of endometriosis by inducing pseudo‐pregnancy with ovarian hormones. Fertility and Sterility1959;10:539‐54. ">Kistner 1959</a>). Combinations of high‐dose oestrogens and progestogens were first used then progestogens alone (<a href="./references#CD001019-bbs2-0043" title="KistnerRW . The use of newer progestins in the treatment of endometriosis. American Journal of Obstetrics and Gynecology1958;75:264‐78. ">Kistner 1958</a>). High doses of oestrogen and progestogen are now only very rarely, if ever, prescribed and modern low‐dose combined oral contraceptive pills (COCPs) are used in clinical practice without much high level evidence of their effectiveness. The combined oral contraceptive pill (COCP) has been observed to reduce menstrual flow and cause decidualisation of endometriotic implants with decreased cell proliferation and increased apoptosis (<a href="./references#CD001019-bbs2-0046" title="MeresmanGF , AugeL , BaranoaRI , LombardiE , TesoneM , SueldoC . Oral contraceptives suppress cell proliferation and enhance apoptosis of ectopic endometrial tissue from patients with endometriosis. Fertility and Sterility2002;77(6):1141‐7. ">Meresman 2002</a>). For some time there has also been epidemiological evidence that the current use of COCPs is associated with a reduced incidence of endometriosis (<a href="./references#CD001019-bbs2-0047" title="VesseyMP , Villard‐MackintoshL , PainterR . Epidemiology of endometriosis in women attending family planning clinics. BMJ1993;306:182‐4. ">Vessey 1993</a>). Moreover, COCPs have an advantage over other hormonal treatments in that they can be taken for prolonged periods of time during reproductive life and are generally more acceptable to women than alternative hormonal treatments, which improves compliance. </p> </section> <section id="CD001019-sec-0048"> <h3 class="title" id="CD001019-sec-0048">Why it is important to do this review</h3> <p>Current guidelines suggest that empirical treatment, without first performing a diagnostic laparoscopy, with an COCP can be given to treat pain symptoms suggestive of endometriosis (<a href="./references#CD001019-bbs2-0035" title="DunselmanGA , VermeulenN , BeckerC , Calhaz‐JorgeC , D'HoogheT , DeBieB , et al. European Society of Human Reproduction Embryology. ESHRE guideline: management of women with endometriosis. Human Reproduction2014;29(3):400‐12. ">Dunselman 2014</a>). This review evaluated the evidence for COCPs in women who experience pain in association with endometriosis, but noted that response to empirical treatment did not confirm the presence or absence of disease and that such treatment might obscure the later development of deep infiltrating endometriosis (more severe disease). </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD001019-sec-0049" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD001019-sec-0049"></div> <p>To determine the effectiveness, safety and cost‐effectiveness of oral contraceptive preparations in the treatment of painful symptoms ascribed to the diagnosis of laparoscopically proven endometriosis. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD001019-sec-0050" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD001019-sec-0050"></div> <section id="CD001019-sec-0051"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD001019-sec-0052"> <h4 class="title">Types of studies</h4> <p>All truly randomised controlled trials (RCT) using COCPs in the treatment of symptomatic endometriosis. We included trials with no treatment rather than a placebo arm and analysed them separately. We excluded quasi‐randomised controlled trials and included cross‐over studies only if pre‐cross‐over data were available. </p> </section> <section id="CD001019-sec-0053"> <h4 class="title">Types of participants</h4> <p>Women of reproductive age who complained of symptoms ascribed to the diagnosis of endometriosis. The diagnosis must have been established during a surgical procedure performed prior to the start of treatment. Studies in both primary and secondary healthcare settings were considered. </p> <p>We excluded trials where women had asymptomatic disease or infertility alone. We excluded trials where the endometrial deposits were outside the uterus. </p> </section> <section id="CD001019-sec-0054"> <h4 class="title">Types of interventions</h4> <p>We considered the following comparisons:</p> <p> <ul id="CD001019-list-0001"> <li> <p>COCP versus placebo/no treatment.</p> </li> <li> <p>COCP versus other medical therapies (danazol, gonadotrophin‐releasing hormone analogues, progestogens, anti‐progestogens, levonorgestrel‐releasing intrauterine systems). </p> </li> <li> <p>COCP versus conservative surgical treatment.</p> </li> </ul> </p> <p>We considered:</p> <p> <ul id="CD001019-list-0002"> <li> <p>only those treatments intended to relieve symptoms;</p> </li> <li> <p>modern COCPs (defined as an ethinylestradiol dose 35 μg or less) taken conventionally, continuously or in a tricyclic regimen versus any other medical therapy, no treatment or placebo irrespective of dosage, route of administration or duration of treatment; </p> </li> <li> <p>studies comparing COCP with medical therapy included the use of levonorgestrel‐releasing intrauterine systems; </p> </li> <li> <p>studies comparing COCP with surgical excision or laser ablation of endometriotic implants or those that claimed to interrupt neural pathways (presacral neurectomy or laparoscopic uterosacral nerve ablation). </p> </li> </ul> </p> <p>We excluded:</p> <p> <ul id="CD001019-list-0003"> <li> <p>studies involving surgical removal of pelvic organs;</p> </li> <li> <p>studies of alternative or complementary therapies;</p> </li> <li> <p>studies exploring the use of hormonal treatment as an adjunct to surgery or other medical treatment for endometriosis. </p> </li> </ul> </p> <p>All studies were included whether or not the duration of symptoms was specified.</p> </section> <section id="CD001019-sec-0055"> <h4 class="title">Types of outcome measures</h4> <section id="CD001019-sec-0056"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD001019-list-0004"> <li> <p>Self‐reported pain (dysmenorrhoea) at the end of treatment (as defined by trialists).</p> </li> </ul> </p> </section> <section id="CD001019-sec-0057"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD001019-list-0005"> <li> <p>Cyclical pain (non‐menstrual): recurrence, frequency and severity (pain scores, days lost off work, use of analgesics). </p> </li> <li> <p>Lower abdominal or pelvic pain of a non‐cyclical nature: recurrence, frequency and severity (pain scores, days lost off work, use of analgesics). </p> </li> <li> <p>Dyspareunia (pain during sexual intercourse): recurrence, frequency and severity (pain scores, days lost off work, use of analgesics). </p> </li> <li> <p>Postcoital pain (pain following sexual intercourse): recurrence, frequency and severity (pain scores, days lost off work, use of analgesics). </p> </li> <li> <p>Dyschezia (pain on defecation): recurrence, frequency and severity (pain scores, days lost off work, use of analgesics). </p> </li> <li> <p>Any other pain symptom ascribed to endometriosis.</p> </li> <li> <p>Participant satisfaction.</p> </li> <li> <p>Withdrawal from treatment group: rates.</p> </li> <li> <p>Adverse effects occurring during therapy (including pregnancy).</p> </li> <li> <p>Adverse effects persisting after treatment.</p> </li> <li> <p>Economic evaluations.</p> </li> </ul> </p> <p>We assessed measures of subjective symptomatic relief (of any or all symptoms) using quantitative measures (such as visual analogue scales) or qualitative measures (such as the terms cured, better, same or worse). Outcome measures for each pain symptom were considered at the end of treatment and, when possible, three, six, nine, 12 and 18 months later. Symptom recurrence could occur both during treatment and after the end of treatment. </p> <p>Objective evaluation of resolution of endometriotic implants at second‐look laparoscopy was also assessed, where possible, using standard scoring systems such as the revised American Society of Reproductive Medicine classification system (<a href="./references#CD001019-bbs2-0030" title="American Society of Reproductive Medicine. Revised American Society of Reproductive Medicine Classification of Endometriosis: 1996. Fertility and Sterility1997;67(5):817‐21. ">ASRM 1997</a>). </p> </section> </section> </section> <section id="CD001019-sec-0058"> <h3 class="title">Search methods for identification of studies</h3> <p>This is an update of the previous review that included one study (<a href="./references#CD001019-bbs2-0051" title="DavisL , KennedySS , MooreJ , PrenticeA . Oral contraceptives for pain associated with endometriosis. Cochrane Database of Systematic Reviews2007, Issue 3. [DOI: 10.1002/14651858.CD001019.pub2] ">Davis 2007</a>). </p> <section id="CD001019-sec-0059"> <h4 class="title">Electronic searches</h4> <p>We searched for all published and unpublished RCTs of any COCP in the treatment of symptomatic endometriosis, without language restrictions and in consultation with the Gynaecology and Fertility Group (CGF) Information Specialist (from database inception to 19 October 2017). </p> <p>We searched:</p> <p> <ul id="CD001019-list-0006"> <li> <p>the Cochrane CGF Specialised Register of Controlled Trials, PROCITE platform (<a href="./appendices#CD001019-sec-0143">Appendix 1</a>); </p> </li> <li> <p>the Cochrane Central Register of Studies Online (CRSO Web platform) (<a href="./appendices#CD001019-sec-0144">Appendix 2</a>); </p> </li> <li> <p>MEDLINE (Epub Ahead of Print, In‐Process and Other Non‐Indexed Citations) Ovid (<a href="./appendices#CD001019-sec-0145">Appendix 3</a>); </p> </li> <li> <p>Embase Ovid (<a href="./appendices#CD001019-sec-0146">Appendix 4</a>); </p> </li> <li> <p>PsycINFO Ovid (<a href="./appendices#CD001019-sec-0147">Appendix 5</a>); </p> </li> <li> <p>CINAHL (Cumulative Index to Nursing and Allied Health Literature) EBSCO (<a href="./appendices#CD001019-sec-0148">Appendix 6</a>). </p> </li> </ul> </p> <p>We combined the MEDLINE search with the Cochrane Highly Sensitive Search Strategy for identifying RCTs, which appears in the <i>Cochrane Handbook of Systematic Reviews of Interventions</i> (Version 5.1.0, Section 6.4.11) (<a href="http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD002249.pub5/full#CD002249-bbs2-0081" target="_blank">Higgins 2011</a>). The Embase, CINAHL and PsycINFO searches were combined with trial filters developed by the Scottish Intercollegiate Guidelines Network (<a href="http://www.sign.ac.uk/methodology/filters.html#random" target="_blank">www.sign.ac.uk/methodology/filters.html#random</a>). </p> <p>We searched the following trials registers to identify ongoing and registered clinical trials (19 October 2017): </p> <p> <ul id="CD001019-list-0007"> <li> <p>ClinicalTrials.gov (a service of the US National Institutes of Health) (<a href="http://www.clinicaltrials.gov" target="_blank">www.clinicaltrials.gov</a>); </p> </li> <li> <p>World Health Organization Clinical Trials Registry Platform (WHO ICTRP) (<a href="http://www.who.int/trialsearch/Default.aspx" target="_blank">www.who.int/trialsearch/Default.aspx</a>). </p> </li> </ul> </p> <p>We used the keywords 'endometriosis AND oral contraceptive.'</p> </section> <section id="CD001019-sec-0060"> <h4 class="title">Searching other resources</h4> <p>We handsearched reference lists of relevant trials and systematic reviews retrieved by the search, and relevant journals and conference abstracts not covered in the CGF Specialised Register of Controlled Trials, in liaison with the Information Specialist. </p> </section> </section> <section id="CD001019-sec-0061"> <h3 class="title" id="CD001019-sec-0061">Data collection and analysis</h3> <section id="CD001019-sec-0062"> <h4 class="title">Selection of studies</h4> <p>In the update of this review, two review authors (JB and TC) independently screened titles and abstracts retrieved by the search in accordance with the inclusion criteria. Three review authors (JB, TC and AP) retrieved and examined for compliance full texts of all potentially eligible studies. We resolved disagreements by discussion. </p> </section> <section id="CD001019-sec-0063"> <h4 class="title">Data extraction and management</h4> <p>Two review authors (of JB, AP and TC) independently extracted and verified study characteristics and outcome data from eligible studies using a data extraction form designed and piloted according to Cochrane guidelines. We sought additional information on trial methodology and results from the authors of three trials (<a href="./references#CD001019-bbs2-0001" title="AliAF , FaridLA , FouadM , OmarED . Continuous oral contraception and leuprolide in the treatment of endometriosis associated pelvic pain. Journal of Endometriosis2013;5 (Suppl 1). AliAFM , FaridLA , FouadM , ElDalyO . Continuous oral contraception and leuprolide in the treatment of endometriosis‐associated pelvic pain. European Journal of Contraception and Reproductive Health Care2013;18 (Suppl 1):S257. ">Ali 2013</a>; <a href="./references#CD001019-bbs2-0011" title="FedeleL , BianchiS , MontefuscoS , FrontinoG , CarmignaniL . A gonadotropin‐releasing hormone agonist versus a continuous oral contraceptive pill in the treatment of bladder endometriosis. Fertility and Sterility2008;90(1):183‐4. ">Fedele 2008</a>; <a href="./references#CD001019-bbs2-0013" title="KitawakiJ , KusukiI , SuganumaI , SasakiA , ItohF , MatsuoS , et al. Long‐term suppression of endometriosis associated pelvic pain with sequential administration of a gonadotropin releasing hormone agonist followed by danazol, oral contraceptives or dienogest. Journal of Endometriosis2012;4(3):150. ">Kitawaki 2012</a>), and received a reply from <a href="./references#CD001019-bbs2-0013" title="KitawakiJ , KusukiI , SuganumaI , SasakiA , ItohF , MatsuoS , et al. Long‐term suppression of endometriosis associated pelvic pain with sequential administration of a gonadotropin releasing hormone agonist followed by danazol, oral contraceptives or dienogest. Journal of Endometriosis2012;4(3):150. ">Kitawaki 2012</a>. </p> <p>Where studies had multiple publications, we collated the reports of the same study so that each study, rather than each report, was the unit of interest for the review, and such studies had a single identifier with multiple references. </p> </section> <section id="CD001019-sec-0064"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (of JB, AP and TC) independently assessed the included studies for risk of bias using the Cochrane 'Risk of bias' assessment tool, which addresses the following domains: selection bias (randomisation and allocation concealment); performance bias (blinding of participants and personnel); detection bias (blinding of outcome assessors); attrition bias (incomplete outcome data); reporting bias (selective reporting) and other bias. Judgements were assigned as recommended in the <i>Cochrane Handbook of Systematic Reviews of Interventions</i> Section 8.5 (<a href="./references#CD001019-bbs2-0038" title="HigginsJP , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>). We resolved disagreements through discussion. We have fully described all judgements and summarised our conclusions in the 'Risk of bias' table in the <a href="./references#CD001019-sec-0159" title="">Characteristics of included studies</a> table. </p> </section> <section id="CD001019-sec-0065"> <h4 class="title">Measures of treatment effect</h4> <p>For dichotomous data, we used the numbers of events in the intervention and control groups of each study to calculate Mantel‐Haenszel risk ratios (RR). For continuous data, if all studies reported the outcomes on the same scale, we calculated mean difference (MDs) between treatment groups. If similar outcomes were reported on different scales, we calculated the standardised mean difference (SMD). We treated ordinal data (e.g. quality of life scores) as continuous data. We presented 95% confidence intervals (CI) for all outcomes. </p> <p>Where data to calculate RRs, MDs or SMDs were not available, we utilised the most detailed numeric data available that could facilitate similar analyses of included studies. </p> </section> <section id="CD001019-sec-0066"> <h4 class="title">Unit of analysis issues</h4> <p>The analysis was per woman randomised.</p> </section> <section id="CD001019-sec-0067"> <h4 class="title">Dealing with missing data</h4> <p>We analysed the data on an intention‐to‐treat basis where possible (i.e. including all randomised participants in analysis, in the groups to which they were randomised). Attempts were made to obtain missing data from the original trialists (i.e. from <a href="./references#CD001019-bbs2-0001" title="AliAF , FaridLA , FouadM , OmarED . Continuous oral contraception and leuprolide in the treatment of endometriosis associated pelvic pain. Journal of Endometriosis2013;5 (Suppl 1). AliAFM , FaridLA , FouadM , ElDalyO . Continuous oral contraception and leuprolide in the treatment of endometriosis‐associated pelvic pain. European Journal of Contraception and Reproductive Health Care2013;18 (Suppl 1):S257. ">Ali 2013</a>). Where these were unobtainable, we undertook analysis only of the available data. Any imputation undertaken was be subjected to sensitivity analysis (see below). </p> <p>If studies reported sufficient detail to calculate MDs or SMDs but no information on associated standard deviation (SD), we assumed the outcome to have a SD equal to the highest SD from other studies within the same analysis. </p> </section> <section id="CD001019-sec-0068"> <h4 class="title">Assessment of heterogeneity</h4> <p>We were unable to assess heterogeneity in this update of the review. In future updates, if sufficient studies are available, we will consider whether the clinical and methodological characteristics of the included studies are sufficiently similar for meta‐analysis to provide a clinically meaningful summary. We will assess statistical heterogeneity by the measure of the I<sup>2</sup> statistic. An I<sup>2</sup> statistic greater than 50% will indicate substantial heterogeneity (<a href="./references#CD001019-bbs2-0038" title="HigginsJP , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>). </p> </section> <section id="CD001019-sec-0069"> <h4 class="title">Assessment of reporting biases</h4> <p>In view of the difficulty of detecting and correcting for publication bias and other reporting biases, we aimed to minimise their potential impact by ensuring a comprehensive search for eligible studies and by being alert for duplication of data. We had planned that, if there were 10 or more trials in an analysis, we would produce a funnel plot to explore the possibility of small‐study effects (a tendency for estimates of the intervention effect to be more beneficial in smaller studies). We were unable to make this assessment in this update of the review. In future updates, we will seek to explore publication bias where sufficient trials are available. </p> </section> <section id="CD001019-sec-0070"> <h4 class="title">Data synthesis</h4> <p>Where studies were sufficiently similar, we combined the data using a fixed‐effect model in the following comparisons: </p> <p> <ul id="CD001019-list-0008"> <li> <p>COCP versus placebo/no treatment;</p> </li> <li> <p>COCP versus other medical treatment.</p> </li> </ul> </p> </section> <section id="CD001019-sec-0071"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We conducted subgroup analysis to determine the separate evidence within the following subgroups: </p> <p> <ul id="CD001019-list-0009"> <li> <p>type of COCP (type A versus type B).</p> </li> </ul> </p> <p>When we detected substantial heterogeneity, we planned to explore possible explanations in subgroup or sensitivity analyses, or both. There was insufficient evidence for us to explore subgroups in this update of the review. </p> </section> <section id="CD001019-sec-0072"> <h4 class="title">Sensitivity analysis</h4> <p>We planned to conduct sensitivity analyses for the primary outcome of this review to determine whether the conclusions were robust to arbitrary decisions made regarding eligibility and analysis. We considered whether the review conclusions would have changed if: </p> <p> <ul id="CD001019-list-0010"> <li> <p>eligibility was restricted to studies without high risk of bias;</p> </li> <li> <p>a random‐effects model had been adopted.</p> </li> </ul> </p> <p>Due to insufficient evidence, we were unable to explore sensitivity analyses in this update of the review. </p> <p>Overall quality of the body of evidence: 'Summary of findings' tables</p> <p>Two review authors (JB and TC) independently prepared 'Summary of findings' tables using GRADE software (<a href="./references#CD001019-bbs2-0037" title="GRADE Working Group, McMaster. GRADEpro GDT. Version accessed 10 November 2017. Hamilton (ON): GRADE Working Group, McMaster, 2015. Available at gradepro.org. ">GRADEpro GDT 2015</a>). These tables evaluated the overall quality of the body of evidence for the primary review outcome (self‐reported pain (dysmenorrhoea) at the end of treatment) for the main review comparisons (COCP versus placebo/no treatment and COCP versus other medical therapies) using GRADE criteria (study limitations, consistency, imprecision, indirectness and publication bias). Judgements about quality (high, moderate, low or very low) were justified and incorporated into the results for each outcome. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD001019-sec-0073" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD001019-sec-0073"></div> <section id="CD001019-sec-0074"> <h3 class="title">Description of studies</h3> <section id="CD001019-sec-0075"> <h4 class="title">Results of the search</h4> <p>The search retrieved 50 articles. Twenty‐three articles were potentially eligible and were retrieved in full text. Upon closer examination, 13 articles (12 studies) did not meet the inclusion criteria due to use of hormonal treatment as an adjunct to surgery. Five studies (six publications) met our inclusion criteria (<a href="./references#CD001019-bbs2-0001" title="AliAF , FaridLA , FouadM , OmarED . Continuous oral contraception and leuprolide in the treatment of endometriosis associated pelvic pain. Journal of Endometriosis2013;5 (Suppl 1). AliAFM , FaridLA , FouadM , ElDalyO . Continuous oral contraception and leuprolide in the treatment of endometriosis‐associated pelvic pain. European Journal of Contraception and Reproductive Health Care2013;18 (Suppl 1):S257. ">Ali 2013</a>; <a href="./references#CD001019-bbs2-0002" title="GuzickDS , HuangLS , BroadmanBA , NealonM , HornsteinMD . Randomized trial of leuprolide versus continuous oral contraceptives in the treatment of endometriosis‐associated pelvic pain. Fertility and Sterility2011;95(5):1568‐73. ">Guzick 2011</a>; <a href="./references#CD001019-bbs2-0003" title="HaradaT , MomoedaM , TaketaniY , HoshiaiH , TerakawaN . Low‐dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo‐controlled, double‐blind, randomized trial. Fertility and Sterility2008;90(5):1583‐88. ">Harada 2008</a>; <a href="./references#CD001019-bbs2-0004" title="HaradaT , KosakaS , EllisenJ , YasudaM , ItoM , MomoedaM . Ethinylestradiol 20 μg/drospireone 3 mg in a flexible extended regiment for the management of endometriosis‐associated pelvic pain: a randomized controlled trial. Fertility and Sterility2017;108(5):798‐805. [DOI: 10.1016/j.fertstert.2017.07.1165] ">Harada 2017</a>; <a href="./references#CD001019-bbs2-0005" title="VercelliniP , TrespidiL , ColomboA , VendolaN , MarchiniM , CrosignaniPG . A gonadotrophin‐releasing hormone agonist versus a low‐dose oral contraceptive for pelvic pain associated with endometriosis. Fertility and Sterility1993;60(1):75‐9. ">Vercellini 1993</a>). <a href="./references#CD001019-bbs2-0005" title="VercelliniP , TrespidiL , ColomboA , VendolaN , MarchiniM , CrosignaniPG . A gonadotrophin‐releasing hormone agonist versus a low‐dose oral contraceptive for pelvic pain associated with endometriosis. Fertility and Sterility1993;60(1):75‐9. ">Vercellini 1993</a> was identified in the original search conducted in 1996, and was included in the previous version of this review (<a href="./references#CD001019-bbs2-0051" title="DavisL , KennedySS , MooreJ , PrenticeA . Oral contraceptives for pain associated with endometriosis. Cochrane Database of Systematic Reviews2007, Issue 3. [DOI: 10.1002/14651858.CD001019.pub2] ">Davis 2007</a>). We excluded 10 studies due to ineligible study design, ineligible population or ineligible treatment (<a href="#CD001019-fig-0001">Figure 1</a>). See: <a href="./references#CD001019-sec-0159" title="">Characteristics of included studies</a> table and <a href="./references#CD001019-sec-0160" title="">Characteristics of excluded studies</a> table. There were no ongoing studies identified. </p> <div class="figure" id="CD001019-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD001019-fig-0001" src="/cdsr/doi/10.1002/14651858.CD001019.pub3/media/CDSR/CD001019/image_n/nCD001019-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> <section id="CD001019-sec-0076"> <h4 class="title">Included studies</h4> <section id="CD001019-sec-0077"> <h5 class="title">Study design and setting</h5> <p>The search identified five parallel‐design RCTs conducted in Egypt (<a href="./references#CD001019-bbs2-0001" title="AliAF , FaridLA , FouadM , OmarED . Continuous oral contraception and leuprolide in the treatment of endometriosis associated pelvic pain. Journal of Endometriosis2013;5 (Suppl 1). AliAFM , FaridLA , FouadM , ElDalyO . Continuous oral contraception and leuprolide in the treatment of endometriosis‐associated pelvic pain. European Journal of Contraception and Reproductive Health Care2013;18 (Suppl 1):S257. ">Ali 2013</a>), US (<a href="./references#CD001019-bbs2-0002" title="GuzickDS , HuangLS , BroadmanBA , NealonM , HornsteinMD . Randomized trial of leuprolide versus continuous oral contraceptives in the treatment of endometriosis‐associated pelvic pain. Fertility and Sterility2011;95(5):1568‐73. ">Guzick 2011</a>), Japan (<a href="./references#CD001019-bbs2-0003" title="HaradaT , MomoedaM , TaketaniY , HoshiaiH , TerakawaN . Low‐dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo‐controlled, double‐blind, randomized trial. Fertility and Sterility2008;90(5):1583‐88. ">Harada 2008</a>; <a href="./references#CD001019-bbs2-0004" title="HaradaT , KosakaS , EllisenJ , YasudaM , ItoM , MomoedaM . Ethinylestradiol 20 μg/drospireone 3 mg in a flexible extended regiment for the management of endometriosis‐associated pelvic pain: a randomized controlled trial. Fertility and Sterility2017;108(5):798‐805. [DOI: 10.1016/j.fertstert.2017.07.1165] ">Harada 2017</a>), and Italy (<a href="./references#CD001019-bbs2-0005" title="VercelliniP , TrespidiL , ColomboA , VendolaN , MarchiniM , CrosignaniPG . A gonadotrophin‐releasing hormone agonist versus a low‐dose oral contraceptive for pelvic pain associated with endometriosis. Fertility and Sterility1993;60(1):75‐9. ">Vercellini 1993</a>). There was one single‐centre trial (<a href="./references#CD001019-bbs2-0005" title="VercelliniP , TrespidiL , ColomboA , VendolaN , MarchiniM , CrosignaniPG . A gonadotrophin‐releasing hormone agonist versus a low‐dose oral contraceptive for pelvic pain associated with endometriosis. Fertility and Sterility1993;60(1):75‐9. ">Vercellini 1993</a>) and three multi‐centre trials (<a href="./references#CD001019-bbs2-0002" title="GuzickDS , HuangLS , BroadmanBA , NealonM , HornsteinMD . Randomized trial of leuprolide versus continuous oral contraceptives in the treatment of endometriosis‐associated pelvic pain. Fertility and Sterility2011;95(5):1568‐73. ">Guzick 2011</a>; <a href="./references#CD001019-bbs2-0003" title="HaradaT , MomoedaM , TaketaniY , HoshiaiH , TerakawaN . Low‐dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo‐controlled, double‐blind, randomized trial. Fertility and Sterility2008;90(5):1583‐88. ">Harada 2008</a>; <a href="./references#CD001019-bbs2-0004" title="HaradaT , KosakaS , EllisenJ , YasudaM , ItoM , MomoedaM . Ethinylestradiol 20 μg/drospireone 3 mg in a flexible extended regiment for the management of endometriosis‐associated pelvic pain: a randomized controlled trial. Fertility and Sterility2017;108(5):798‐805. [DOI: 10.1016/j.fertstert.2017.07.1165] ">Harada 2017</a>) conducted in hospitals. One trial was only available as an abstract and did not specify details of trial site (<a href="./references#CD001019-bbs2-0001" title="AliAF , FaridLA , FouadM , OmarED . Continuous oral contraception and leuprolide in the treatment of endometriosis associated pelvic pain. Journal of Endometriosis2013;5 (Suppl 1). AliAFM , FaridLA , FouadM , ElDalyO . Continuous oral contraception and leuprolide in the treatment of endometriosis‐associated pelvic pain. European Journal of Contraception and Reproductive Health Care2013;18 (Suppl 1):S257. ">Ali 2013</a>). </p> </section> <section id="CD001019-sec-0078"> <h5 class="title">Participants</h5> <p>The studies included 612 women experiencing pelvic pain associated with endometriosis (<a href="./references#CD001019-bbs2-0001" title="AliAF , FaridLA , FouadM , OmarED . Continuous oral contraception and leuprolide in the treatment of endometriosis associated pelvic pain. Journal of Endometriosis2013;5 (Suppl 1). AliAFM , FaridLA , FouadM , ElDalyO . Continuous oral contraception and leuprolide in the treatment of endometriosis‐associated pelvic pain. European Journal of Contraception and Reproductive Health Care2013;18 (Suppl 1):S257. ">Ali 2013</a>: 150 women, <a href="./references#CD001019-bbs2-0002" title="GuzickDS , HuangLS , BroadmanBA , NealonM , HornsteinMD . Randomized trial of leuprolide versus continuous oral contraceptives in the treatment of endometriosis‐associated pelvic pain. Fertility and Sterility2011;95(5):1568‐73. ">Guzick 2011</a>: 47 women, <a href="./references#CD001019-bbs2-0003" title="HaradaT , MomoedaM , TaketaniY , HoshiaiH , TerakawaN . Low‐dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo‐controlled, double‐blind, randomized trial. Fertility and Sterility2008;90(5):1583‐88. ">Harada 2008</a>: 100 women, <a href="./references#CD001019-bbs2-0004" title="HaradaT , KosakaS , EllisenJ , YasudaM , ItoM , MomoedaM . Ethinylestradiol 20 μg/drospireone 3 mg in a flexible extended regiment for the management of endometriosis‐associated pelvic pain: a randomized controlled trial. Fertility and Sterility2017;108(5):798‐805. [DOI: 10.1016/j.fertstert.2017.07.1165] ">Harada 2017</a>: 258 women; <a href="./references#CD001019-bbs2-0005" title="VercelliniP , TrespidiL , ColomboA , VendolaN , MarchiniM , CrosignaniPG . A gonadotrophin‐releasing hormone agonist versus a low‐dose oral contraceptive for pelvic pain associated with endometriosis. Fertility and Sterility1993;60(1):75‐9. ">Vercellini 1993</a>: 57 women). </p> <p>Mean (± SD) ages ranged across studies from 27 ± 5 years (<a href="./references#CD001019-bbs2-0005" title="VercelliniP , TrespidiL , ColomboA , VendolaN , MarchiniM , CrosignaniPG . A gonadotrophin‐releasing hormone agonist versus a low‐dose oral contraceptive for pelvic pain associated with endometriosis. Fertility and Sterility1993;60(1):75‐9. ">Vercellini 1993</a>) to 35.7 ± 6.9 years (<a href="./references#CD001019-bbs2-0004" title="HaradaT , KosakaS , EllisenJ , YasudaM , ItoM , MomoedaM . Ethinylestradiol 20 μg/drospireone 3 mg in a flexible extended regiment for the management of endometriosis‐associated pelvic pain: a randomized controlled trial. Fertility and Sterility2017;108(5):798‐805. [DOI: 10.1016/j.fertstert.2017.07.1165] ">Harada 2017</a>). The proportion of parous women included in each trial was comparable (<a href="./references#CD001019-bbs2-0005" title="VercelliniP , TrespidiL , ColomboA , VendolaN , MarchiniM , CrosignaniPG . A gonadotrophin‐releasing hormone agonist versus a low‐dose oral contraceptive for pelvic pain associated with endometriosis. Fertility and Sterility1993;60(1):75‐9. ">Vercellini 1993</a>: 26%; <a href="./references#CD001019-bbs2-0002" title="GuzickDS , HuangLS , BroadmanBA , NealonM , HornsteinMD . Randomized trial of leuprolide versus continuous oral contraceptives in the treatment of endometriosis‐associated pelvic pain. Fertility and Sterility2011;95(5):1568‐73. ">Guzick 2011</a>: 28%; <a href="./references#CD001019-bbs2-0003" title="HaradaT , MomoedaM , TaketaniY , HoshiaiH , TerakawaN . Low‐dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo‐controlled, double‐blind, randomized trial. Fertility and Sterility2008;90(5):1583‐88. ">Harada 2008</a>: 30%). Detailed information about participant demographics was not available in the <a href="./references#CD001019-bbs2-0001" title="AliAF , FaridLA , FouadM , OmarED . Continuous oral contraception and leuprolide in the treatment of endometriosis associated pelvic pain. Journal of Endometriosis2013;5 (Suppl 1). AliAFM , FaridLA , FouadM , ElDalyO . Continuous oral contraception and leuprolide in the treatment of endometriosis‐associated pelvic pain. European Journal of Contraception and Reproductive Health Care2013;18 (Suppl 1):S257. ">Ali 2013</a> abstract. <a href="./references#CD001019-bbs2-0004" title="HaradaT , KosakaS , EllisenJ , YasudaM , ItoM , MomoedaM . Ethinylestradiol 20 μg/drospireone 3 mg in a flexible extended regiment for the management of endometriosis‐associated pelvic pain: a randomized controlled trial. Fertility and Sterility2017;108(5):798‐805. [DOI: 10.1016/j.fertstert.2017.07.1165] ">Harada 2017</a> did not report parity. </p> <p><a href="./references#CD001019-bbs2-0002" title="GuzickDS , HuangLS , BroadmanBA , NealonM , HornsteinMD . Randomized trial of leuprolide versus continuous oral contraceptives in the treatment of endometriosis‐associated pelvic pain. Fertility and Sterility2011;95(5):1568‐73. ">Guzick 2011</a> reported that endometriosis was diagnosed by laparoscopy or laparotomy within three years of trial entry. Either histology had to be consistent with endometriosis or operative records had to indicate visual evidence of lesions consistent with endometriosis. <a href="./references#CD001019-bbs2-0003" title="HaradaT , MomoedaM , TaketaniY , HoshiaiH , TerakawaN . Low‐dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo‐controlled, double‐blind, randomized trial. Fertility and Sterility2008;90(5):1583‐88. ">Harada 2008</a> and <a href="./references#CD001019-bbs2-0004" title="HaradaT , KosakaS , EllisenJ , YasudaM , ItoM , MomoedaM . Ethinylestradiol 20 μg/drospireone 3 mg in a flexible extended regiment for the management of endometriosis‐associated pelvic pain: a randomized controlled trial. Fertility and Sterility2017;108(5):798‐805. [DOI: 10.1016/j.fertstert.2017.07.1165] ">Harada 2017</a> reported that endometriosis was diagnosed by laparoscopy or laparotomy or endometrioma were diagnosed by ultrasound scan or magnetic resonance imaging. <a href="./references#CD001019-bbs2-0005" title="VercelliniP , TrespidiL , ColomboA , VendolaN , MarchiniM , CrosignaniPG . A gonadotrophin‐releasing hormone agonist versus a low‐dose oral contraceptive for pelvic pain associated with endometriosis. Fertility and Sterility1993;60(1):75‐9. ">Vercellini 1993</a> reported that diagnosis of endometriosis was by laparoscopy or laparotomy. <a href="./references#CD001019-bbs2-0001" title="AliAF , FaridLA , FouadM , OmarED . Continuous oral contraception and leuprolide in the treatment of endometriosis associated pelvic pain. Journal of Endometriosis2013;5 (Suppl 1). AliAFM , FaridLA , FouadM , ElDalyO . Continuous oral contraception and leuprolide in the treatment of endometriosis‐associated pelvic pain. European Journal of Contraception and Reproductive Health Care2013;18 (Suppl 1):S257. ">Ali 2013</a> provided no details for how endometriosis was diagnosed. </p> </section> <section id="CD001019-sec-0079"> <h5 class="title">Interventions</h5> <p>The durations of intervention were three months (<a href="./references#CD001019-bbs2-0001" title="AliAF , FaridLA , FouadM , OmarED . Continuous oral contraception and leuprolide in the treatment of endometriosis associated pelvic pain. Journal of Endometriosis2013;5 (Suppl 1). AliAFM , FaridLA , FouadM , ElDalyO . Continuous oral contraception and leuprolide in the treatment of endometriosis‐associated pelvic pain. European Journal of Contraception and Reproductive Health Care2013;18 (Suppl 1):S257. ">Ali 2013</a>), four months (<a href="./references#CD001019-bbs2-0003" title="HaradaT , MomoedaM , TaketaniY , HoshiaiH , TerakawaN . Low‐dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo‐controlled, double‐blind, randomized trial. Fertility and Sterility2008;90(5):1583‐88. ">Harada 2008</a>), six months (<a href="./references#CD001019-bbs2-0004" title="HaradaT , KosakaS , EllisenJ , YasudaM , ItoM , MomoedaM . Ethinylestradiol 20 μg/drospireone 3 mg in a flexible extended regiment for the management of endometriosis‐associated pelvic pain: a randomized controlled trial. Fertility and Sterility2017;108(5):798‐805. [DOI: 10.1016/j.fertstert.2017.07.1165] ">Harada 2017</a>; <a href="./references#CD001019-bbs2-0005" title="VercelliniP , TrespidiL , ColomboA , VendolaN , MarchiniM , CrosignaniPG . A gonadotrophin‐releasing hormone agonist versus a low‐dose oral contraceptive for pelvic pain associated with endometriosis. Fertility and Sterility1993;60(1):75‐9. ">Vercellini 1993</a>), and 11 months (<a href="./references#CD001019-bbs2-0002" title="GuzickDS , HuangLS , BroadmanBA , NealonM , HornsteinMD . Randomized trial of leuprolide versus continuous oral contraceptives in the treatment of endometriosis‐associated pelvic pain. Fertility and Sterility2011;95(5):1568‐73. ">Guzick 2011</a>). </p> <p>Three trials used a monophasic COCP consisting of ethinylestradiol 0.035 mg and norethisterone 1 mg (<a href="./references#CD001019-bbs2-0001" title="AliAF , FaridLA , FouadM , OmarED . Continuous oral contraception and leuprolide in the treatment of endometriosis associated pelvic pain. Journal of Endometriosis2013;5 (Suppl 1). AliAFM , FaridLA , FouadM , ElDalyO . Continuous oral contraception and leuprolide in the treatment of endometriosis‐associated pelvic pain. European Journal of Contraception and Reproductive Health Care2013;18 (Suppl 1):S257. ">Ali 2013</a>; <a href="./references#CD001019-bbs2-0002" title="GuzickDS , HuangLS , BroadmanBA , NealonM , HornsteinMD . Randomized trial of leuprolide versus continuous oral contraceptives in the treatment of endometriosis‐associated pelvic pain. Fertility and Sterility2011;95(5):1568‐73. ">Guzick 2011</a>; <a href="./references#CD001019-bbs2-0003" title="HaradaT , MomoedaM , TaketaniY , HoshiaiH , TerakawaN . Low‐dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo‐controlled, double‐blind, randomized trial. Fertility and Sterility2008;90(5):1583‐88. ">Harada 2008</a>), one trial used a formulation of ethinylestradiol 0.020 mg and desogestrel 0.15 mg with the option to increase the dosage of ethinylestradiol to 0.030 mg if spotting or breakthrough bleeding occurred (<a href="./references#CD001019-bbs2-0005" title="VercelliniP , TrespidiL , ColomboA , VendolaN , MarchiniM , CrosignaniPG . A gonadotrophin‐releasing hormone agonist versus a low‐dose oral contraceptive for pelvic pain associated with endometriosis. Fertility and Sterility1993;60(1):75‐9. ">Vercellini 1993</a>), and the fifth trial used ethinylestradiol 0.02 mg and drospirenone 3 mg in a flexible extended regimen. </p> <p>Two trials used continuous (daily) administration for the duration of the intervention (<a href="./references#CD001019-bbs2-0001" title="AliAF , FaridLA , FouadM , OmarED . Continuous oral contraception and leuprolide in the treatment of endometriosis associated pelvic pain. Journal of Endometriosis2013;5 (Suppl 1). AliAFM , FaridLA , FouadM , ElDalyO . Continuous oral contraception and leuprolide in the treatment of endometriosis‐associated pelvic pain. European Journal of Contraception and Reproductive Health Care2013;18 (Suppl 1):S257. ">Ali 2013</a>; <a href="./references#CD001019-bbs2-0002" title="GuzickDS , HuangLS , BroadmanBA , NealonM , HornsteinMD . Randomized trial of leuprolide versus continuous oral contraceptives in the treatment of endometriosis‐associated pelvic pain. Fertility and Sterility2011;95(5):1568‐73. ">Guzick 2011</a>), and three trials used cyclical administration (21 days of active pills and seven days of placebo tablets) (<a href="./references#CD001019-bbs2-0003" title="HaradaT , MomoedaM , TaketaniY , HoshiaiH , TerakawaN . Low‐dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo‐controlled, double‐blind, randomized trial. Fertility and Sterility2008;90(5):1583‐88. ">Harada 2008</a>; <a href="./references#CD001019-bbs2-0004" title="HaradaT , KosakaS , EllisenJ , YasudaM , ItoM , MomoedaM . Ethinylestradiol 20 μg/drospireone 3 mg in a flexible extended regiment for the management of endometriosis‐associated pelvic pain: a randomized controlled trial. Fertility and Sterility2017;108(5):798‐805. [DOI: 10.1016/j.fertstert.2017.07.1165] ">Harada 2017</a>; <a href="./references#CD001019-bbs2-0005" title="VercelliniP , TrespidiL , ColomboA , VendolaN , MarchiniM , CrosignaniPG . A gonadotrophin‐releasing hormone agonist versus a low‐dose oral contraceptive for pelvic pain associated with endometriosis. Fertility and Sterility1993;60(1):75‐9. ">Vercellini 1993)</a>. </p> </section> <section id="CD001019-sec-0080"> <h5 class="title">Comparisons</h5> <p>Three trials used a gonadotropin‐releasing hormone analogue as the comparison (leuprolide 11.25 mg intramuscularly 12 weekly (<a href="./references#CD001019-bbs2-0002" title="GuzickDS , HuangLS , BroadmanBA , NealonM , HornsteinMD . Randomized trial of leuprolide versus continuous oral contraceptives in the treatment of endometriosis‐associated pelvic pain. Fertility and Sterility2011;95(5):1568‐73. ">Guzick 2011</a>); leuprolide 3.75 mg intramuscularly monthly (<a href="./references#CD001019-bbs2-0001" title="AliAF , FaridLA , FouadM , OmarED . Continuous oral contraception and leuprolide in the treatment of endometriosis associated pelvic pain. Journal of Endometriosis2013;5 (Suppl 1). AliAFM , FaridLA , FouadM , ElDalyO . Continuous oral contraception and leuprolide in the treatment of endometriosis‐associated pelvic pain. European Journal of Contraception and Reproductive Health Care2013;18 (Suppl 1):S257. ">Ali 2013</a>); goserelin 3.6 mg subcutaneously (<a href="./references#CD001019-bbs2-0005" title="VercelliniP , TrespidiL , ColomboA , VendolaN , MarchiniM , CrosignaniPG . A gonadotrophin‐releasing hormone agonist versus a low‐dose oral contraceptive for pelvic pain associated with endometriosis. Fertility and Sterility1993;60(1):75‐9. ">Vercellini 1993</a>)). </p> <p>Two trials used an inactive placebo of identical appearance as the comparison to facilitate blinding (<a href="./references#CD001019-bbs2-0003" title="HaradaT , MomoedaM , TaketaniY , HoshiaiH , TerakawaN . Low‐dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo‐controlled, double‐blind, randomized trial. Fertility and Sterility2008;90(5):1583‐88. ">Harada 2008</a>; <a href="./references#CD001019-bbs2-0004" title="HaradaT , KosakaS , EllisenJ , YasudaM , ItoM , MomoedaM . Ethinylestradiol 20 μg/drospireone 3 mg in a flexible extended regiment for the management of endometriosis‐associated pelvic pain: a randomized controlled trial. Fertility and Sterility2017;108(5):798‐805. [DOI: 10.1016/j.fertstert.2017.07.1165] ">Harada 2017</a>). Participants were also blinded in the <a href="./references#CD001019-bbs2-0002" title="GuzickDS , HuangLS , BroadmanBA , NealonM , HornsteinMD . Randomized trial of leuprolide versus continuous oral contraceptives in the treatment of endometriosis‐associated pelvic pain. Fertility and Sterility2011;95(5):1568‐73. ">Guzick 2011</a> trial and this was facilitated by administering a normal saline injection every 12 weeks to the women in the COCP group, and administering a daily oral "hormonal add‐back" of norethisterone acetate 5 mg identical in appearance to the COCP to the women in the leuprolide group. </p> </section> <section id="CD001019-sec-0081"> <h5 class="title">Outcomes</h5> <p>Four trials used the Biberoglu and Behrman (<a href="./references#CD001019-bbs2-0033" title="BiberogluKO , BehrmanSJ . Dosage aspects of danazol therapy in endometriosis: short‐term and long‐term effectiveness. American Journal of Obstetrics and Gynecology1981;139:645. ">Biberoglu 1981</a>) verbal rating score (<a href="./references#CD001019-bbs2-0001" title="AliAF , FaridLA , FouadM , OmarED . Continuous oral contraception and leuprolide in the treatment of endometriosis associated pelvic pain. Journal of Endometriosis2013;5 (Suppl 1). AliAFM , FaridLA , FouadM , ElDalyO . Continuous oral contraception and leuprolide in the treatment of endometriosis‐associated pelvic pain. European Journal of Contraception and Reproductive Health Care2013;18 (Suppl 1):S257. ">Ali 2013</a>; <a href="./references#CD001019-bbs2-0002" title="GuzickDS , HuangLS , BroadmanBA , NealonM , HornsteinMD . Randomized trial of leuprolide versus continuous oral contraceptives in the treatment of endometriosis‐associated pelvic pain. Fertility and Sterility2011;95(5):1568‐73. ">Guzick 2011</a>; <a href="./references#CD001019-bbs2-0005" title="VercelliniP , TrespidiL , ColomboA , VendolaN , MarchiniM , CrosignaniPG . A gonadotrophin‐releasing hormone agonist versus a low‐dose oral contraceptive for pelvic pain associated with endometriosis. Fertility and Sterility1993;60(1):75‐9. ">Vercellini 1993</a>) or a modified version of it (<a href="./references#CD001019-bbs2-0003" title="HaradaT , MomoedaM , TaketaniY , HoshiaiH , TerakawaN . Low‐dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo‐controlled, double‐blind, randomized trial. Fertility and Sterility2008;90(5):1583‐88. ">Harada 2008</a>) to assess pain at the end of treatment, as well as other visual or numerical pain ratings methods. <a href="./references#CD001019-bbs2-0004" title="HaradaT , KosakaS , EllisenJ , YasudaM , ItoM , MomoedaM . Ethinylestradiol 20 μg/drospireone 3 mg in a flexible extended regiment for the management of endometriosis‐associated pelvic pain: a randomized controlled trial. Fertility and Sterility2017;108(5):798‐805. [DOI: 10.1016/j.fertstert.2017.07.1165] ">Harada 2017</a> reported data on reduction in pain from baseline to end of treatment. <a href="./references#CD001019-bbs2-0003" title="HaradaT , MomoedaM , TaketaniY , HoshiaiH , TerakawaN . Low‐dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo‐controlled, double‐blind, randomized trial. Fertility and Sterility2008;90(5):1583‐88. ">Harada 2008</a>; <a href="./references#CD001019-bbs2-0004" title="HaradaT , KosakaS , EllisenJ , YasudaM , ItoM , MomoedaM . Ethinylestradiol 20 μg/drospireone 3 mg in a flexible extended regiment for the management of endometriosis‐associated pelvic pain: a randomized controlled trial. Fertility and Sterility2017;108(5):798‐805. [DOI: 10.1016/j.fertstert.2017.07.1165] ">Harada 2017</a>; and <a href="./references#CD001019-bbs2-0005" title="VercelliniP , TrespidiL , ColomboA , VendolaN , MarchiniM , CrosignaniPG . A gonadotrophin‐releasing hormone agonist versus a low‐dose oral contraceptive for pelvic pain associated with endometriosis. Fertility and Sterility1993;60(1):75‐9. ">Vercellini 1993</a> reported adverse effects of treatment. <a href="./references#CD001019-bbs2-0002" title="GuzickDS , HuangLS , BroadmanBA , NealonM , HornsteinMD . Randomized trial of leuprolide versus continuous oral contraceptives in the treatment of endometriosis‐associated pelvic pain. Fertility and Sterility2011;95(5):1568‐73. ">Guzick 2011</a> included data on adverse effects but this was not in a format that could be included in a meta‐analysis. There were no available data for meta‐analysis from the <a href="./references#CD001019-bbs2-0001" title="AliAF , FaridLA , FouadM , OmarED . Continuous oral contraception and leuprolide in the treatment of endometriosis associated pelvic pain. Journal of Endometriosis2013;5 (Suppl 1). AliAFM , FaridLA , FouadM , ElDalyO . Continuous oral contraception and leuprolide in the treatment of endometriosis‐associated pelvic pain. European Journal of Contraception and Reproductive Health Care2013;18 (Suppl 1):S257. ">Ali 2013</a> trial, as this was only available in abstract form. </p> </section> </section> <section id="CD001019-sec-0082"> <h4 class="title">Excluded studies</h4> <p>We excluded 23 studies, for the following reasons.</p> <p> <ul id="CD001019-list-0011"> <li> <p>Five studies had ineligible study design. Following review of the full‐text articles, we confirmed that four studies were not RCTs (<a href="./references#CD001019-bbs2-0007" title="CarusoS , IraciM , CianciS , FavaV , CasellaE , CianciA . Comparative, open‐label prospective study on the quality of life and sexual function of women affected by endometriosis‐associated pelvic pain on 2 mg dienogest/30 micro g ethinyl estradiol continuous or 21/7 regimen oral contraceptive. Journal of Endocrinological Investigation2016;39(8):923‐31. ">Caruso 2016</a>; <a href="./references#CD001019-bbs2-0013" title="KitawakiJ , KusukiI , SuganumaI , SasakiA , ItohF , MatsuoS , et al. Long‐term suppression of endometriosis associated pelvic pain with sequential administration of a gonadotropin releasing hormone agonist followed by danazol, oral contraceptives or dienogest. Journal of Endometriosis2012;4(3):150. ">Kitawaki 2012</a>; <a href="./references#CD001019-bbs2-0022" title="TanakaY , MoriT , ItoF , KoshibaA , KusukiI , KitawakiJ . Effects of low‐dose combined drospirenone‐ethinylestradiol on perimenstrual symptoms experienced by women with endometriosis. International Journal of Gynecology and Obstetrics2016;135(2):135‐9. ">Tanaka 2016</a>; <a href="./references#CD001019-bbs2-0023" title="TaniguchiF , EnatsuA , OtaI , TodaT , ArataK , HaradaT . Effects of low dose oral contraceptive pill containing drospirenone/ethinylestradiol in patients with endometrioma. European Journal of Obstetrics, Gynecology, and Reproductive Biology2015;191:116‐20. ">Taniguchi 2015</a>), and one was a secondary report of a larger non‐randomised trial (<a href="./references#CD001019-bbs2-0011" title="FedeleL , BianchiS , MontefuscoS , FrontinoG , CarmignaniL . A gonadotropin‐releasing hormone agonist versus a continuous oral contraceptive pill in the treatment of bladder endometriosis. Fertility and Sterility2008;90(1):183‐4. ">Fedele 2008</a>). </p> </li> <li> <p>Three trials were conducted in healthy women without endometriosis, or with primary dysmenorrhoea but no identifiable pelvic disease (<a href="./references#CD001019-bbs2-0006" title="CarusoS , Iraci SareriM , AgnelloC , RomanoM , Lo PrestiL , MalandrinoC , et al. Conventional vs. extended‐cycle oral contraceptives on the quality of sexual life: comparison between two regimens containing 3 mg drospirenone and 20 micro g ethinyl estradiol. Journal of Sexual Medicine2011;8(5):1478‐85. ">Caruso 2011</a>; <a href="./references#CD001019-bbs2-0017" title="PortmanD , ReapeK , HaitH , HowardB . Reduction in dysmenorrhea severity in women using a 91‐day extended regimen oral contraceptive compared to a 28‐day regimen oral contraceptive for the treatment of cyclic pelvic pain. Fertility and Sterility2011;96(3 Suppl):S110. ">Portman 2011</a>; <a href="./references#CD001019-bbs2-0021" title="StrowitzkiT , KirschB , ElliesenJ . Efficacy of ethinylestradiol 20 mug/drospirenone 3 mg in a flexible extended regimen in women with moderate‐to‐severe primary dysmenorrhoea: An open‐label, multicentre, randomised, controlled study. Journal of Family Planning and Reproductive Health Care2012;38(2):94‐101. ">Strowitzki 2012</a>). </p> </li> <li> <p>Twelve trials (13 publications) used hormonal therapy as an adjunct to surgery (<a href="./references#CD001019-bbs2-0008" title="CheewadhanaraksS , ChoksuchatC , DhanaworavibulK , LiabsuetrakulT . Postoperative depot medroxyprogesterone acetate versus continuous oral contraceptive pills in the treatment of endometriosis‐associated pain: a randomized comparative trial. Gynecologic and Obstetric Investigation2012;74(2):151‐6. ">Cheewadhanaraks 2012</a>; <a href="./references#CD001019-bbs2-0009" title="CucinellaG , GraneseR , CalagnaG , SvelatoA , SaittaS , TonniG , et al. Oral contraceptives in the prevention of endometrioma recurrence: does the different progestins used make a difference?. Archives of Gynecology &amp; Obstetrics2013;288(4):821‐7. ">Cucinella 2013</a>; <a href="./references#CD001019-bbs2-0012" title="GraneseR , PerinoA , CalagnaG , SaittaS , DeFranciscisP , ColacurciN , et al. Gonadotrophin‐releasing hormone analogue or dienogest plus estradiol valerate to prevent pain recurrence after laparoscopic surgery for endometriosis: a multi‐center randomized trial. Acta Obstetricia et Gynecologica Scandinavica2015;94(6):637‐45. ">Granese 2015</a>; <a href="./references#CD001019-bbs2-0015" title="MoawadA , SalahA , Abou‐RiaH , Abd‐ElzaherM , MadkourW . Is continuous use of long term OCP's more significant than cyclic use in prevention of endometrioma recurrence after laparoscopic excision? A randomized controlled trial. Human Reproduction2012;27(Suppl 2):ii66‐7. ">Moawad 2012</a>; <a href="./references#CD001019-bbs2-0016" title="MuziiL , ManeschiF , MaranaR , PorporaMG , ZupiE , BellatiF , et al. Oral estroprogestins after laparoscopic surgery to excise endometriomas: continuous or cyclic administration? Results of a multicenter randomized study. Journal of Minimally Invasive Gynecology2011;18(2):173‐8. ">Muzii 2011</a>; <a href="./references#CD001019-bbs2-0018" title="SeracchioliR , MabroukM , FrascaC , ManuzziL , MontanariG , KeramydaA , et al. Long‐term cyclic and continuous oral contraceptive therapy and endometrioma recurrence: a randomized controlled trial. Fertility and Sterility2010;93(1):52‐6. SeracchioliR , MabroukM , FrascaC , ManuzziL , SavelliL , VenturoliS . Long‐term oral contraceptive pills and postoperative pain management after laparoscopic excision of ovarian endometrioma: a randomized controlled trial. Fertility and Sterility2010;94(2):464‐71. ">Seracchioli 2010</a>; <a href="./references#CD001019-bbs2-0019" title="SestiF , PietropolliA , CapozzoloT , BroccoliP , PierangeliS , BolleaMR , et al. Hormonal suppression treatment or dietary therapy versus placebo in the control of painful symptoms after conservative surgery for endometriosis stage III‐IV. A randomized comparative trial. Fertility and Sterility2007;88(6):1541‐7. ">Sesti 2007</a>; <a href="./references#CD001019-bbs2-0025" title="VercelliniP , PietropaoloG , DeGiorgiO , PasinR , ChiodiniA , CrosignaniPG . Treatment of symptomatic rectovaginal endometriosis with an estrogen‐progestogen combination versus low‐dose norethindrone acetate. Fertility and Sterility2005;84(5):1375‐87. ">Vercellini 2005</a>; <a href="./references#CD001019-bbs2-0024" title="VercelliniP , DeGiorgiO , MosconiP , StellatoG , VicentiniS , CrosignaniPG . Cyproterone acetate versus a continuous monophasic oral contraceptive in the treatment of recurrent pelvic pain after conservative surgery for symptomatic endometriosis. Fertility and Sterility2002;77(1):52‐61. ">Vercellini 2002</a>; <a href="./references#CD001019-bbs2-0026" title="XuXW , WangLD , ZhuXQ , YanLZ , GuanYT , ZhuSC , et al. Levonorgestrel‐releasing intrauterine system and combined oral contraceptives as conservative treatments for recurrent ovarian endometriosis: a comparative clinical study. Chung‐Hua i Hsueh Tsa Chih [Chinese Medical Journal]2011;91(15):1047‐50. ">Xu 2011</a>; <a href="./references#CD001019-bbs2-0027" title="ZhuS , LiuD , HuangW , WangQ , ZhouL , FengG . Post‐laparoscopic oral contraceptive combined with Chinese herbal mixture in treatment of infertility and pain associated with minimal or mild endometriosis: a randomized controlled trial. BMC Complementary and Alternative Medicine2014;14(1):222. ">Zhu 2014</a>), or other medical therapy (<a href="./references#CD001019-bbs2-0014" title="LongQQ , ZhangSF , HanY , ChenH , LiXL , HuaKQ , et al. Clinical efficacy and safety of gonadotropin releasing hormone agonist combined with estrogen‐dydrogesteronea in treatment of endometriosis. Chung‐Hua Fu Chan Ko Tsa Chih [Chinese Journal of Obstetrics &amp; Gynecology]2010;45(4):247‐51. ">Long 2010</a>). </p> </li> <li> <p>Two trials used high doses of hormone that were not comparable to modern low‐dose contraceptive preparations (<a href="./references#CD001019-bbs2-0010" title="FedeleL , ArcainiL , BianchiS , BaglioniA , VercilliniP . Comparison of cyproterone acetate and danazol in the treatment of pelvic pain associated with endometriosis. Obstetrics and Gynecology1989;73(6):1000‐4. ">Fedele 1989</a>; <a href="./references#CD001019-bbs2-0020" title="ShturkalevI , KatsulovA . Results of clinical trials of Ovostat as a contraceptive and therapeutic agent. Akusherstvo i Ginekologiia1970;9(5):383‐7. ">Shturkalev 1970</a>), and so did not meet the inclusion criteria. </p> </li> </ul> </p> </section> </section> <section id="CD001019-sec-0083"> <h3 class="title">Risk of bias in included studies</h3> <p>See <a href="#CD001019-fig-0002">Figure 2</a>; <a href="#CD001019-fig-0003">Figure 3</a>. </p> <div class="figure" id="CD001019-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Methodological quality graph: review authors' judgements about each methodological quality item presented as percentages across all included studies." data-id="CD001019-fig-0002" src="/cdsr/doi/10.1002/14651858.CD001019.pub3/media/CDSR/CD001019/image_n/nCD001019-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Methodological quality graph: review authors' judgements about each methodological quality item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD001019-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Methodological quality summary: review authors' judgements about each methodological quality item for each included study." data-id="CD001019-fig-0003" src="/cdsr/doi/10.1002/14651858.CD001019.pub3/media/CDSR/CD001019/image_n/nCD001019-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Methodological quality summary: review authors' judgements about each methodological quality item for each included study. </p> </div> </div> </div> <section id="CD001019-sec-0084"> <h4 class="title">Allocation</h4> <section id="CD001019-sec-0085"> <h5 class="title">Random sequence generation</h5> <p>Three trials provided insufficient details and were at unclear risk of bias related to random sequence generation (<a href="./references#CD001019-bbs2-0001" title="AliAF , FaridLA , FouadM , OmarED . Continuous oral contraception and leuprolide in the treatment of endometriosis associated pelvic pain. Journal of Endometriosis2013;5 (Suppl 1). AliAFM , FaridLA , FouadM , ElDalyO . Continuous oral contraception and leuprolide in the treatment of endometriosis‐associated pelvic pain. European Journal of Contraception and Reproductive Health Care2013;18 (Suppl 1):S257. ">Ali 2013</a>; <a href="./references#CD001019-bbs2-0002" title="GuzickDS , HuangLS , BroadmanBA , NealonM , HornsteinMD . Randomized trial of leuprolide versus continuous oral contraceptives in the treatment of endometriosis‐associated pelvic pain. Fertility and Sterility2011;95(5):1568‐73. ">Guzick 2011</a>; <a href="./references#CD001019-bbs2-0005" title="VercelliniP , TrespidiL , ColomboA , VendolaN , MarchiniM , CrosignaniPG . A gonadotrophin‐releasing hormone agonist versus a low‐dose oral contraceptive for pelvic pain associated with endometriosis. Fertility and Sterility1993;60(1):75‐9. ">Vercellini 1993</a>). <a href="./references#CD001019-bbs2-0003" title="HaradaT , MomoedaM , TaketaniY , HoshiaiH , TerakawaN . Low‐dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo‐controlled, double‐blind, randomized trial. Fertility and Sterility2008;90(5):1583‐88. ">Harada 2008</a> and <a href="./references#CD001019-bbs2-0004" title="HaradaT , KosakaS , EllisenJ , YasudaM , ItoM , MomoedaM . Ethinylestradiol 20 μg/drospireone 3 mg in a flexible extended regiment for the management of endometriosis‐associated pelvic pain: a randomized controlled trial. Fertility and Sterility2017;108(5):798‐805. [DOI: 10.1016/j.fertstert.2017.07.1165] ">Harada 2017</a> were at high risk of bias for random sequence generation as randomisation was conducted by the pharmaceutical company funding the trial. </p> </section> <section id="CD001019-sec-0086"> <h5 class="title">Allocation concealment</h5> <p>Four trials provided insufficient details and were at unclear risk of bias related to allocation concealment (<a href="./references#CD001019-bbs2-0001" title="AliAF , FaridLA , FouadM , OmarED . Continuous oral contraception and leuprolide in the treatment of endometriosis associated pelvic pain. Journal of Endometriosis2013;5 (Suppl 1). AliAFM , FaridLA , FouadM , ElDalyO . Continuous oral contraception and leuprolide in the treatment of endometriosis‐associated pelvic pain. European Journal of Contraception and Reproductive Health Care2013;18 (Suppl 1):S257. ">Ali 2013</a>; <a href="./references#CD001019-bbs2-0002" title="GuzickDS , HuangLS , BroadmanBA , NealonM , HornsteinMD . Randomized trial of leuprolide versus continuous oral contraceptives in the treatment of endometriosis‐associated pelvic pain. Fertility and Sterility2011;95(5):1568‐73. ">Guzick 2011</a>; <a href="./references#CD001019-bbs2-0004" title="HaradaT , KosakaS , EllisenJ , YasudaM , ItoM , MomoedaM . Ethinylestradiol 20 μg/drospireone 3 mg in a flexible extended regiment for the management of endometriosis‐associated pelvic pain: a randomized controlled trial. Fertility and Sterility2017;108(5):798‐805. [DOI: 10.1016/j.fertstert.2017.07.1165] ">Harada 2017</a>; <a href="./references#CD001019-bbs2-0005" title="VercelliniP , TrespidiL , ColomboA , VendolaN , MarchiniM , CrosignaniPG . A gonadotrophin‐releasing hormone agonist versus a low‐dose oral contraceptive for pelvic pain associated with endometriosis. Fertility and Sterility1993;60(1):75‐9. ">Vercellini 1993</a>). <a href="./references#CD001019-bbs2-0003" title="HaradaT , MomoedaM , TaketaniY , HoshiaiH , TerakawaN . Low‐dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo‐controlled, double‐blind, randomized trial. Fertility and Sterility2008;90(5):1583‐88. ">Harada 2008</a> stated that allocation concealment was accomplished by the pharmaceutical company, and was not broken until after all data were collected. This was at high risk of bias for this domain. The company funding the trial was also responsible for allocation concealment; no details were provided as to whether sequentially numbered opaque envelopes were used. </p> </section> </section> <section id="CD001019-sec-0087"> <h4 class="title">Blinding</h4> <p>Participants were blinded in <a href="./references#CD001019-bbs2-0002" title="GuzickDS , HuangLS , BroadmanBA , NealonM , HornsteinMD . Randomized trial of leuprolide versus continuous oral contraceptives in the treatment of endometriosis‐associated pelvic pain. Fertility and Sterility2011;95(5):1568‐73. ">Guzick 2011</a> and the trial was at low risk for performance bias. <a href="./references#CD001019-bbs2-0003" title="HaradaT , MomoedaM , TaketaniY , HoshiaiH , TerakawaN . Low‐dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo‐controlled, double‐blind, randomized trial. Fertility and Sterility2008;90(5):1583‐88. ">Harada 2008</a> and <a href="./references#CD001019-bbs2-0004" title="HaradaT , KosakaS , EllisenJ , YasudaM , ItoM , MomoedaM . Ethinylestradiol 20 μg/drospireone 3 mg in a flexible extended regiment for the management of endometriosis‐associated pelvic pain: a randomized controlled trial. Fertility and Sterility2017;108(5):798‐805. [DOI: 10.1016/j.fertstert.2017.07.1165] ">Harada 2017</a> stated that participants and clinicians were blinded by using a placebo. However, as the trial was sponsored by the pharmaceutical company who were also responsible for randomisation and allocation concealment in <a href="./references#CD001019-bbs2-0003" title="HaradaT , MomoedaM , TaketaniY , HoshiaiH , TerakawaN . Low‐dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo‐controlled, double‐blind, randomized trial. Fertility and Sterility2008;90(5):1583‐88. ">Harada 2008</a>, it is possible that there was some communication between the clinicians and the sponsors. We have judged this trial at unclear risk of performance bias. <a href="./references#CD001019-bbs2-0002" title="GuzickDS , HuangLS , BroadmanBA , NealonM , HornsteinMD . Randomized trial of leuprolide versus continuous oral contraceptives in the treatment of endometriosis‐associated pelvic pain. Fertility and Sterility2011;95(5):1568‐73. ">Guzick 2011</a>; <a href="./references#CD001019-bbs2-0003" title="HaradaT , MomoedaM , TaketaniY , HoshiaiH , TerakawaN . Low‐dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo‐controlled, double‐blind, randomized trial. Fertility and Sterility2008;90(5):1583‐88. ">Harada 2008</a>; and <a href="./references#CD001019-bbs2-0004" title="HaradaT , KosakaS , EllisenJ , YasudaM , ItoM , MomoedaM . Ethinylestradiol 20 μg/drospireone 3 mg in a flexible extended regiment for the management of endometriosis‐associated pelvic pain: a randomized controlled trial. Fertility and Sterility2017;108(5):798‐805. [DOI: 10.1016/j.fertstert.2017.07.1165] ">Harada 2017</a> did not stipulate that outcome assessors were blinded, and were at unclear risk of detection bias. <a href="./references#CD001019-bbs2-0005" title="VercelliniP , TrespidiL , ColomboA , VendolaN , MarchiniM , CrosignaniPG . A gonadotrophin‐releasing hormone agonist versus a low‐dose oral contraceptive for pelvic pain associated with endometriosis. Fertility and Sterility1993;60(1):75‐9. ">Vercellini 1993</a> was at high risk of performance bias and detection bias as participants and clinicians were aware of the treatment allocation and blinding was not undertaken, due to the nature of the treatment administration (injection versus oral). <a href="./references#CD001019-bbs2-0001" title="AliAF , FaridLA , FouadM , OmarED . Continuous oral contraception and leuprolide in the treatment of endometriosis associated pelvic pain. Journal of Endometriosis2013;5 (Suppl 1). AliAFM , FaridLA , FouadM , ElDalyO . Continuous oral contraception and leuprolide in the treatment of endometriosis‐associated pelvic pain. European Journal of Contraception and Reproductive Health Care2013;18 (Suppl 1):S257. ">Ali 2013</a> was only available as a conference abstract and provided no details on numbers of participants allocated to each group or final number analysed. </p> </section> <section id="CD001019-sec-0088"> <h4 class="title">Incomplete outcome data</h4> <p>Three trials were at high risk of attrition bias. <a href="./references#CD001019-bbs2-0001" title="AliAF , FaridLA , FouadM , OmarED . Continuous oral contraception and leuprolide in the treatment of endometriosis associated pelvic pain. Journal of Endometriosis2013;5 (Suppl 1). AliAFM , FaridLA , FouadM , ElDalyO . Continuous oral contraception and leuprolide in the treatment of endometriosis‐associated pelvic pain. European Journal of Contraception and Reproductive Health Care2013;18 (Suppl 1):S257. ">Ali 2013</a> was at high risk of bias as no details were provided on allocation to groups for final number of women analysed. <a href="./references#CD001019-bbs2-0002" title="GuzickDS , HuangLS , BroadmanBA , NealonM , HornsteinMD . Randomized trial of leuprolide versus continuous oral contraceptives in the treatment of endometriosis‐associated pelvic pain. Fertility and Sterility2011;95(5):1568‐73. ">Guzick 2011</a> was at high risk of attrition bias. Of the 47 women randomised, seven dropped out immediately (three in the OCP group and four in the leuprolide group), and only 24 women completed the trial although it is unclear which groups they were allocated to. <a href="./references#CD001019-bbs2-0004" title="HaradaT , KosakaS , EllisenJ , YasudaM , ItoM , MomoedaM . Ethinylestradiol 20 μg/drospireone 3 mg in a flexible extended regiment for the management of endometriosis‐associated pelvic pain: a randomized controlled trial. Fertility and Sterility2017;108(5):798‐805. [DOI: 10.1016/j.fertstert.2017.07.1165] ">Harada 2017</a> reported that 20% in each group discontinued the study by 24 weeks of treatment. </p> <p>Seven of 57 women randomised in the <a href="./references#CD001019-bbs2-0005" title="VercelliniP , TrespidiL , ColomboA , VendolaN , MarchiniM , CrosignaniPG . A gonadotrophin‐releasing hormone agonist versus a low‐dose oral contraceptive for pelvic pain associated with endometriosis. Fertility and Sterility1993;60(1):75‐9. ">Vercellini 1993</a> trial did not complete follow‐up (four in the COCP group, three in the goserelin group). This was rated at low risk of attrition bias. Fourteen of the 100 women randomised discontinued the <a href="./references#CD001019-bbs2-0003" title="HaradaT , MomoedaM , TaketaniY , HoshiaiH , TerakawaN . Low‐dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo‐controlled, double‐blind, randomized trial. Fertility and Sterility2008;90(5):1583‐88. ">Harada 2008</a> trial (seven in each group) but had data included in the analysis. This was rated at low risk for attrition bias. </p> </section> <section id="CD001019-sec-0089"> <h4 class="title">Selective reporting</h4> <p>None of the trials had published protocols. <a href="./references#CD001019-bbs2-0005" title="VercelliniP , TrespidiL , ColomboA , VendolaN , MarchiniM , CrosignaniPG . A gonadotrophin‐releasing hormone agonist versus a low‐dose oral contraceptive for pelvic pain associated with endometriosis. Fertility and Sterility1993;60(1):75‐9. ">Vercellini 1993</a> and <a href="./references#CD001019-bbs2-0004" title="HaradaT , KosakaS , EllisenJ , YasudaM , ItoM , MomoedaM . Ethinylestradiol 20 μg/drospireone 3 mg in a flexible extended regiment for the management of endometriosis‐associated pelvic pain: a randomized controlled trial. Fertility and Sterility2017;108(5):798‐805. [DOI: 10.1016/j.fertstert.2017.07.1165] ">Harada 2017</a> were at low risk of selective reporting bias as all prespecified outcomes were reported. <a href="./references#CD001019-bbs2-0003" title="HaradaT , MomoedaM , TaketaniY , HoshiaiH , TerakawaN . Low‐dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo‐controlled, double‐blind, randomized trial. Fertility and Sterility2008;90(5):1583‐88. ">Harada 2008</a> was at unclear risk of selective reporting as there was no protocol and the trial did not appear to have been registered. <a href="./references#CD001019-bbs2-0002" title="GuzickDS , HuangLS , BroadmanBA , NealonM , HornsteinMD . Randomized trial of leuprolide versus continuous oral contraceptives in the treatment of endometriosis‐associated pelvic pain. Fertility and Sterility2011;95(5):1568‐73. ">Guzick 2011</a> was at unclear risk of selective reporting bias as adverse effects were reported that were not prespecified. The <a href="./references#CD001019-bbs2-0001" title="AliAF , FaridLA , FouadM , OmarED . Continuous oral contraception and leuprolide in the treatment of endometriosis associated pelvic pain. Journal of Endometriosis2013;5 (Suppl 1). AliAFM , FaridLA , FouadM , ElDalyO . Continuous oral contraception and leuprolide in the treatment of endometriosis‐associated pelvic pain. European Journal of Contraception and Reproductive Health Care2013;18 (Suppl 1):S257. ">Ali 2013</a> trial was at high risk of bias as it was only available as a conference abstract and reported only one outcome. </p> </section> <section id="CD001019-sec-0090"> <h4 class="title">Other potential sources of bias</h4> <p><a href="./references#CD001019-bbs2-0002" title="GuzickDS , HuangLS , BroadmanBA , NealonM , HornsteinMD . Randomized trial of leuprolide versus continuous oral contraceptives in the treatment of endometriosis‐associated pelvic pain. Fertility and Sterility2011;95(5):1568‐73. ">Guzick 2011</a> and <a href="./references#CD001019-bbs2-0005" title="VercelliniP , TrespidiL , ColomboA , VendolaN , MarchiniM , CrosignaniPG . A gonadotrophin‐releasing hormone agonist versus a low‐dose oral contraceptive for pelvic pain associated with endometriosis. Fertility and Sterility1993;60(1):75‐9. ">Vercellini 1993</a> were at low risk of other potential sources of bias. The <a href="./references#CD001019-bbs2-0001" title="AliAF , FaridLA , FouadM , OmarED . Continuous oral contraception and leuprolide in the treatment of endometriosis associated pelvic pain. Journal of Endometriosis2013;5 (Suppl 1). AliAFM , FaridLA , FouadM , ElDalyO . Continuous oral contraception and leuprolide in the treatment of endometriosis‐associated pelvic pain. European Journal of Contraception and Reproductive Health Care2013;18 (Suppl 1):S257. ">Ali 2013</a> trial at unclear risk of bias as there was insufficient information to enable a judgement. <a href="./references#CD001019-bbs2-0003" title="HaradaT , MomoedaM , TaketaniY , HoshiaiH , TerakawaN . Low‐dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo‐controlled, double‐blind, randomized trial. Fertility and Sterility2008;90(5):1583‐88. ">Harada 2008</a> and <a href="./references#CD001019-bbs2-0004" title="HaradaT , KosakaS , EllisenJ , YasudaM , ItoM , MomoedaM . Ethinylestradiol 20 μg/drospireone 3 mg in a flexible extended regiment for the management of endometriosis‐associated pelvic pain: a randomized controlled trial. Fertility and Sterility2017;108(5):798‐805. [DOI: 10.1016/j.fertstert.2017.07.1165] ">Harada 2017</a> were at high risk of bias as authors received consulting fees/payments from the pharmaceutical company that also provided the randomisation or allocation concealment (or both) service. </p> </section> </section> <section id="CD001019-sec-0091"> <h3 class="title" id="CD001019-sec-0091">Effects of interventions</h3> <p>See: <a href="./full#CD001019-tbl-0001"><b>Summary of findings for the main comparison</b> Combined oral contraceptive pill compared to placebo or no treatment for pain associated with endometriosis</a>; <a href="./full#CD001019-tbl-0002"><b>Summary of findings 2</b> Combined oral contraceptive pill compared to other medical treatment for pain associated with endometriosis</a> </p> <section id="CD001019-sec-0092"> <h4 class="title">1. Combined oral contraceptive pill versus placebo/no treatment</h4> <p>Two studies with 354 women compared COCP with placebo (<a href="./references#CD001019-bbs2-0003" title="HaradaT , MomoedaM , TaketaniY , HoshiaiH , TerakawaN . Low‐dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo‐controlled, double‐blind, randomized trial. Fertility and Sterility2008;90(5):1583‐88. ">Harada 2008</a>; <a href="./references#CD001019-bbs2-0004" title="HaradaT , KosakaS , EllisenJ , YasudaM , ItoM , MomoedaM . Ethinylestradiol 20 μg/drospireone 3 mg in a flexible extended regiment for the management of endometriosis‐associated pelvic pain: a randomized controlled trial. Fertility and Sterility2017;108(5):798‐805. [DOI: 10.1016/j.fertstert.2017.07.1165] ">Harada 2017</a>). </p> <section id="CD001019-sec-0093"> <h5 class="title">Primary outcome</h5> <section id="CD001019-sec-0094"> <h6 class="title">1.1. Self‐reported pain (dysmenorrhoea) at the end of treatment</h6> <p>Treatment with COCP was associated with a lower score on the Dysmenorrhoea verbal rating scale compared with placebo (MD ‐1.30 points, 95% CI ‐1.84 to ‐0.76; 1 RCT, 96 women; very low quality evidence), a lower score on the Dysmenorrhoea Visual Analogue Scale compared with placebo (MD ‐23.68 points, 95% CI ‐28.75 to ‐18.62, 2 RCTs, 327 women; very low quality evidence) at the end of treatment and a greater reduction in menstrual pain from baseline to the end of treatment (MD 2.10 points, 95% CI 1.38 to 2.82; 1 RCT, 169 women; very low quality evidence) (<a href="./references#CD001019-fig-0008" title="">Analysis 1.1</a>; <a href="#CD001019-fig-0004">Figure 4</a>). </p> <div class="figure" id="CD001019-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Combined oral contractive pill (COCP) versus placebo/no treatment, outcome: 1.1 Self‐reported pain (dysmenorrhoea) at end of treatment." data-id="CD001019-fig-0004" src="/cdsr/doi/10.1002/14651858.CD001019.pub3/media/CDSR/CD001019/image_n/nCD001019-AFig-FIG04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Combined oral contractive pill (COCP) versus placebo/no treatment, outcome: 1.1 Self‐reported pain (dysmenorrhoea) at end of treatment. </p> </div> </div> </div> </section> </section> <section id="CD001019-sec-0095"> <h5 class="title">Secondary outcomes</h5> <section id="CD001019-sec-0096"> <h6 class="title">1.2. Cyclical pain (non‐menstrual)</h6> <p>At the end of treatment, there was no clear evidence of a difference between women treated with COCP and women treated with placebo for the non‐menstrual pain verbal rating scale (MD 0.10, 95% CI ‐0.48 to 0.68; 1 RCT, 96 women) or for the non‐menstrual pain visual analogue scale (MD ‐1.90, 95% CI ‐11.72 to 7.92; 1 RCT, 96 women). There was a greater mean reduction in menstrual pain from baseline to the end of treatment for women in the COCP group compared with placebo (MD 1.00 points, 95% CI 0.30 to 1.70; 1 RCT, 212 women) (<a href="./references#CD001019-fig-0009" title="">Analysis 1.2</a>). </p> </section> <section id="CD001019-sec-0097"> <h6 class="title">1.3. Lower abdominal or pelvic pain of a non‐cyclical nature</h6> <p>We found no data on lower abdominal or pelvic pain of a non‐cyclical nature.</p> </section> <section id="CD001019-sec-0098"> <h6 class="title">1.4. Dyspareunia (pain during sexual intercourse)</h6> <p>Women in the COCP group reported a greater reduction in 'severest dyspareunia' from baseline to the end of treatment compared with placebo (MD 1.40 points, 95% CI 0.46 to 2.34; 1 RCT, 89 women) (<a href="./references#CD001019-fig-0010" title="">Analysis 1.3</a>). </p> </section> <section id="CD001019-sec-0099"> <h6 class="title">1.5. Postcoital pain (pain following sexual intercourse)</h6> <p>We found no data on postcoital pain.</p> </section> <section id="CD001019-sec-0100"> <h6 class="title">1.6. Dyschezia (pain on defecation)</h6> <p>Women in the COCP group reported a greater reduction in the 'severest defecation pain' from baseline to the end of treatment compared with placebo (MD 1.20 points, 95% CI 0.56 to 1.84; 1 RCT, 231 women) (<a href="./references#CD001019-fig-0011" title="">Analysis 1.4</a>). </p> </section> <section id="CD001019-sec-0101"> <h6 class="title">1.7. Any other pain symptom ascribed to endometriosis</h6> <p>We found no data on any other pain symptom ascribed to endometriosis.</p> </section> <section id="CD001019-sec-0102"> <h6 class="title">1.8. Participant satisfaction</h6> <p>Women in the COCP group reported a greater level of satisfaction (very highly/highly satisfied) compared with placebo (RR 4.24, 95% CI 2.44 to 7.37; 1 RCT, 258 women) (<a href="./references#CD001019-fig-0012" title="">Analysis 1.5</a>). </p> </section> <section id="CD001019-sec-0103"> <h6 class="title">1.9. Withdrawal from treatment group</h6> <p>There was no clear evidence of a difference in withdrawal from the study between the COCP and placebo groups (RR 1.34, 95% CI 0.83 to 2.18; 2 RCTs, 354 women) (<a href="./references#CD001019-fig-0013" title="">Analysis 1.6</a>). </p> </section> <section id="CD001019-sec-0104"> <h6 class="title">1.10. Adverse effects occurring during therapy</h6> <section id="CD001019-sec-0105"> <p><b>Pregnancy</b></p> <p>There was no clear evidence of a difference between COCP and placebo groups for pregnancy (RR 2.88, 95% CI 0.12 to 68.98; 1 RCT, 96 women). There was only one event reported in the COCP group and no events in the placebo group. </p> </section> <section id="CD001019-sec-0106"> <p><b>Spotting/irregular bleeding/menorrhagia</b></p> <p>Women treated with COCP were more likely to experience spotting, irregular bleeding or menorrhagia compared with women treated with placebo (RR 2.44, 95% CI 1.44 to 4.15; 2 RCTs, 354 women). </p> </section> <section id="CD001019-sec-0107"> <p><b>Nausea</b></p> <p>Women treated with COCP were more likely to experience nausea compared with women treated with placebo (RR 4.14, 95% CI 1.79 to 9.54; 2 RCTs, 354 women). </p> </section> <section id="CD001019-sec-0108"> <p><b>Any treatment‐associated adverse effect</b></p> <p>Women treated with COCP were more likely to experience any treatment‐associated adverse effect compared with women treated with placebo (RR 1.17, 95% CI 1.00 to 1.36; 1 RCT, 258 women). (<a href="./references#CD001019-fig-0014" title="">Analysis 1.7</a>). </p> </section> </section> <section id="CD001019-sec-0109"> <h6 class="title">1.11 Adverse effects persisting after treatment</h6> <p>We found no data on adverse effects persisting after treatment.</p> </section> <section id="CD001019-sec-0110"> <h6 class="title">1.12. Economic evaluations</h6> <p>We found no data on economic evaluations.</p> </section> </section> </section> <section id="CD001019-sec-0111"> <h4 class="title">2. Combined oral contraceptive pill versus other medical therapies</h4> <p>One study (57 women) compared cyclic low‐dose monophasic COCP, containing ethinylestradiol 0.02 mg plus desogestrel 0.15 mg with goserelin 3.6 mg subcutaneous depot formulation monthly for six months (<a href="./references#CD001019-bbs2-0005" title="VercelliniP , TrespidiL , ColomboA , VendolaN , MarchiniM , CrosignaniPG . A gonadotrophin‐releasing hormone agonist versus a low‐dose oral contraceptive for pelvic pain associated with endometriosis. Fertility and Sterility1993;60(1):75‐9. ">Vercellini 1993</a>). Two studies compared COCP (ethinylestradiol 0.035 mg plus norethisterone 1 mg) with leuprolide 11.25 mg intramuscularly 12 weekly (<a href="./references#CD001019-bbs2-0001" title="AliAF , FaridLA , FouadM , OmarED . Continuous oral contraception and leuprolide in the treatment of endometriosis associated pelvic pain. Journal of Endometriosis2013;5 (Suppl 1). AliAFM , FaridLA , FouadM , ElDalyO . Continuous oral contraception and leuprolide in the treatment of endometriosis‐associated pelvic pain. European Journal of Contraception and Reproductive Health Care2013;18 (Suppl 1):S257. ">Ali 2013</a>; <a href="./references#CD001019-bbs2-0002" title="GuzickDS , HuangLS , BroadmanBA , NealonM , HornsteinMD . Randomized trial of leuprolide versus continuous oral contraceptives in the treatment of endometriosis‐associated pelvic pain. Fertility and Sterility2011;95(5):1568‐73. ">Guzick 2011</a>). There were no data from <a href="./references#CD001019-bbs2-0001" title="AliAF , FaridLA , FouadM , OmarED . Continuous oral contraception and leuprolide in the treatment of endometriosis associated pelvic pain. Journal of Endometriosis2013;5 (Suppl 1). AliAFM , FaridLA , FouadM , ElDalyO . Continuous oral contraception and leuprolide in the treatment of endometriosis‐associated pelvic pain. European Journal of Contraception and Reproductive Health Care2013;18 (Suppl 1):S257. ">Ali 2013</a> and <a href="./references#CD001019-bbs2-0002" title="GuzickDS , HuangLS , BroadmanBA , NealonM , HornsteinMD . Randomized trial of leuprolide versus continuous oral contraceptives in the treatment of endometriosis‐associated pelvic pain. Fertility and Sterility2011;95(5):1568‐73. ">Guzick 2011</a> that could be included in a meta‐analysis although there were declines in Biberoglu and Behrman pain scores, Numerical Rating Scores and Beck Depression Inventory scores from baseline in both treatment groups, but no differences between groups, reported in <a href="./references#CD001019-bbs2-0002" title="GuzickDS , HuangLS , BroadmanBA , NealonM , HornsteinMD . Randomized trial of leuprolide versus continuous oral contraceptives in the treatment of endometriosis‐associated pelvic pain. Fertility and Sterility2011;95(5):1568‐73. ">Guzick 2011</a>. </p> <section id="CD001019-sec-0112"> <h5 class="title">Primary outcome</h5> <section id="CD001019-sec-0113"> <h6 class="title">2.1. Self‐reported pain (dysmenorrhoea) at the end of treatment</h6> <p>At the end of treatment, no women in the goserelin group reported dysmenorrhoea as they were amenorrhoeic, therefore, no direct comparison could be made between groups. In the COCP group, the visual analogue scale (mean ± SD) was 3.7 ± 2.1 (24 women) and the verbal rating scale (mean ± SD) was 2.4 ± 1.7 (24 women). At six months' follow‐up, there was no clear evidence of a difference between women treated with COCP and women treated with goserelin for measures of dysmenorrhoea on a visual analogue scale (MD ‐0.10, 95% CI ‐1.28 to 1.08; 1 RCT, 50 women; very low quality evidence) or a verbal rating scale (MD ‐0.10, 95% CI ‐0.99 to 0.79; 1 RCT, 50 women; very low quality evidence) (<a href="./references#CD001019-fig-0015" title="">Analysis 2.1</a>; <a href="#CD001019-fig-0005">Figure 5</a>). </p> <div class="figure" id="CD001019-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 2 Combined oral contractive pill (COCP) versus other medical treatment, outcome: 2.1 Self‐reported pain (dysmenorrhoea) at end of treatment (continuous data)." data-id="CD001019-fig-0005" src="/cdsr/doi/10.1002/14651858.CD001019.pub3/media/CDSR/CD001019/image_n/nCD001019-AFig-FIG05.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 2 Combined oral contractive pill (COCP) versus other medical treatment, outcome: 2.1 Self‐reported pain (dysmenorrhoea) at end of treatment (continuous data). </p> </div> </div> </div> <p>At the end of treatment, all women in the goserelin group were amenorrhoeic and, therefore, no comparison could be made between the groups. In the COCP group, 17/24 women reported mild or complete absence of dysmenorrhoea at the end of treatment and 3/24 women reported complete absence of pain. At six months' follow‐up, there was no clear evidence of a difference between the COCP and goserelin groups for reporting mild or zero pain using a visual analogue scale (5/24 women with COCP versus 6/26 women with goserelin; RR 0.90, 95% CI 0.32 to 2.58; 1 RCT, 50 women) or complete absence of pain (0/24 women with COCP and 1/26 women with goserelin; RR 0.36, 95% CI 0.02 to 8.43; 1 RCT, 50 women; very low quality evidence) (<a href="./references#CD001019-fig-0016" title="">Analysis 2.2</a>; <a href="#CD001019-fig-0006">Figure 6</a>). </p> <div class="figure" id="CD001019-fig-0006"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 6</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 2 Combined oral contractive pill (COCP) versus other medical treatment, outcome: 2.2 Self‐reported pain (dysmenorrhoea): VAS (dichotomous data)." data-id="CD001019-fig-0006" src="/cdsr/doi/10.1002/14651858.CD001019.pub3/media/CDSR/CD001019/image_n/nCD001019-AFig-FIG06.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 2 Combined oral contractive pill (COCP) versus other medical treatment, outcome: 2.2 Self‐reported pain (dysmenorrhoea): VAS (dichotomous data). </p> </div> </div> </div> <p>At the end of treatment, all women in the goserelin group were amenorrhoeic and therefore no comparison could be made between the groups. In the COCP group, 18/24 women reported mild or complete absence of dysmenorrhoea at the end of treatment and 3/24 women reported complete absence of pain. At six months' follow‐up, there was no clear evidence of a difference between the COCP and goserelin groups for reporting mild or zero pain using a verbal rating scale (17/22 women with COCP versus 18/22 women with goserelin; RR 0.94, 95% CI 0.70 to 1.28; 1 RCT, 44 women) or complete absence of pain (24/24 women with OCP versus 25/25 women with goserelin; RR 1.00, 95% CI 0.93 to 1.08; 1 RCT, 49 women; low quality evidence) (<a href="./references#CD001019-fig-0017" title="">Analysis 2.3</a>; <a href="#CD001019-fig-0007">Figure 7</a>). </p> <div class="figure" id="CD001019-fig-0007"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 7</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 2 Combined oral contractive pill (COCP) versus other medical treatment, outcome: 2.3 Self‐reported pain (dysmenorrhoea): VRS (dichotomous data)." data-id="CD001019-fig-0007" src="/cdsr/doi/10.1002/14651858.CD001019.pub3/media/CDSR/CD001019/image_n/nCD001019-AFig-FIG07.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 2 Combined oral contractive pill (COCP) versus other medical treatment, outcome: 2.3 Self‐reported pain (dysmenorrhoea): VRS (dichotomous data). </p> </div> </div> </div> </section> </section> <section id="CD001019-sec-0114"> <h5 class="title">Secondary outcomes</h5> <section id="CD001019-sec-0115"> <h6 class="title">2.2. Cyclical pain (non‐menstrual)</h6> <section id="CD001019-sec-0116"> <p><b>Overall non‐menstrual pain</b></p> <p>At the end of treatment, there was no clear difference between women treated with COCP and women treated with goserelin for non‐menstrual pain using a visual analogue scale (MD ‐0.20, 95% CI ‐1.51 to 1.11; 1 RCT, 50 women) or using a verbal rating scale (MD 0.40, 95% CI ‐0.51 to 1.31; 1 RCT, 50 women). </p> <p>At six months' follow‐up, there was no clear difference between women treated with COCP and women treated with goserelin for non‐menstrual pain using a visual analogue scale (MD ‐0.30, 95% CI ‐1.85 to 1.25; 1 RCT, 50 women) or using a verbal rating scale (MD 0.00, 95% CI ‐1.08 to 1.08; 1 RCT, 50 women) (<a href="./references#CD001019-fig-0018" title="">Analysis 2.4</a>). </p> </section> <section id="CD001019-sec-0117"> <p><b>Mild or zero non‐menstrual pain or complete absence of pain</b></p> <p>At the end of treatment, there was no clear difference between women treated with COCP and women treated with goserelin for mild or zero non‐menstrual pain (RR 0.99, 95% CI 0.81 to 1.21; 1 RCT, 50 women) or complete absence of pain (RR 0.98, 95% CI 0.51 to 1.89; 1 RCT, 50 women) using a visual analogue scale or for mild or zero non‐menstrual pain (RR 0.99, 95% CI 0.84 to 1.17; 1 RCT, 50 women) or complete absence of pain (RR 0.98, 95% CI 0.51 to 1.89; 1 RCT, 50 women) using a verbal rating scale (<a href="./references#CD001019-fig-0019" title="">Analysis 2.5</a>). </p> <p>At six months' follow‐up, there was no clear difference between women treated with COCP and women treated with goserelin for mild or zero non‐menstrual pain (RR 1.14, 95% CI 0.85 to 1.53; 1 RCT, 50 women) or complete absence of pain (RR 0.87, 95% CI 0.26 to 2.85; 1 RCT, 50 women) using a visual analogue scale or for mild or zero non‐menstrual pain (RR 0.91, 95% CI 0.63 to 1.32; 1 RCT, 50 women) or complete absence of pain (RR 0.87, 95% CI 0.26 to 2.85; 1 RCT, 50 women) using a verbal rating scale (<a href="./references#CD001019-fig-0019" title="">Analysis 2.5</a>). </p> </section> </section> <section id="CD001019-sec-0118"> <h6 class="title">2.3. Lower abdominal or pelvic pain of a non‐cyclical nature</h6> <p>We found no data on lower abdominal or pelvic pain of a non‐cyclical nature.</p> </section> <section id="CD001019-sec-0119"> <h6 class="title">2.4. Dyspareunia (pain during sexual intercourse)</h6> <section id="CD001019-sec-0120"> <p><b>Overall dyspareunia</b></p> <p>At the end of treatment, there was an increase in the experience of dyspareunia in women treated with COCP compared with women treated with goserelin using a visual analogue scale (MD 1.80, 95% CI 0.18 to 3.42; 1 RCT, 43 women) although there was no evidence of a difference between groups for dyspareunia using a verbal rating scale (MD 0.10, 95% CI ‐0.41 to 0.61; 1 RCT, 43 women) (<a href="./references#CD001019-fig-0020" title="">Analysis 2.6</a>). </p> <p>At six months' follow‐up, there was no clear difference between women treated with COCP and women treated with goserelin for dyspareunia using a visual analogue scale (MD 0.40, 95% CI ‐1.30 to 2.10; 1 RCT, 43 women) or a verbal rating scale (MD 0.10, 95% CI ‐0.47 to 0.67; 1 RCT, 43 women) (<a href="./references#CD001019-fig-0020" title="">Analysis 2.6</a>). </p> </section> <section id="CD001019-sec-0121"> <p><b>Mild or zero dyspareunia or complete absence of dyspareunia</b></p> <p>At the end of treatment, there was no clear difference between women treated with COCP and women treated with goserelin for mild or zero dyspareunia (RR 0.73, 95% CI 0.53 to 1.02; 1 RCT, 43 women) or complete absence of dyspareunia (RR 0.52, 95% CI 0.19 to 1.48; 1 RCT, 43 women) using a visual analogue scale or mild or zero dyspareunia (RR 0.96, 95% CI 0.56 to 1.65; 1 RCT, 25 women) or complete absence of dyspareunia (RR 1.35, 95% CI 0.99 to 1.84; 1 RCT, 38 women) using a verbal rating scale (<a href="./references#CD001019-fig-0021" title="">Analysis 2.7</a>). </p> <p>At six months' follow‐up, there was no clear difference between women treated with COCP and women treated with goserelin for mild or zero dyspareunia (RR 1.05, 95% CI 0.62 to 1.78; 1 RCT, 43 women) or complete absence of pain (RR 0.70, 95% CI 0.13 to 3.77; 1 RCT, 43 women) using a visual analogue scale or mild or zero dyspareunia (RR 0.96, 95% CI 0.55 to 1.68; 1 RCT, 43 women) or complete absence of pain (RR 0.70, 95% CI 0.13 to 3.77; 1 RCT, 43 women) using a verbal rating scale (<a href="./references#CD001019-fig-0021" title="">Analysis 2.7</a>). </p> </section> </section> <section id="CD001019-sec-0122"> <h6 class="title">2.5. Postcoital pain (pain following sexual intercourse)</h6> <p>We found no data on postcoital pain.</p> </section> <section id="CD001019-sec-0123"> <h6 class="title">2.6. Dyschezia (pain on defecation)</h6> <p>We found no data on dyschezia.</p> </section> <section id="CD001019-sec-0124"> <h6 class="title">2.7. Any other pain symptom ascribed to endometriosis</h6> <p>We found no data on any other pain symptom ascribed to endometriosis.</p> </section> <section id="CD001019-sec-0125"> <h6 class="title">2.8. Participant satisfaction</h6> <p>We found no data on participant satisfaction.</p> </section> <section id="CD001019-sec-0126"> <h6 class="title">2.9. Withdrawal from treatment group</h6> <p>There was no clear evidence of a difference between the COCP group and the goserelin group for withdrawal from treatment (RR 1.38, 95% CI 0.34 to 5.62; 1 RCT, 57 women). Seven women in total withdrew from the study: because of pregnancy (one woman), lost to follow‐up (one woman) and use of additional hormonal therapy after the end of treatment (one woman) in the goserelin group; and lost to follow‐up (one woman), additional hormonal therapy (two women) and adverse effects (one woman) in the COCP group (<a href="./references#CD001019-fig-0022" title="">Analysis 2.8</a>). </p> </section> <section id="CD001019-sec-0127"> <h6 class="title">2.10. Adverse effects occurring during therapy</h6> <p>Women in the COCP group were less likely to experience hot flushes than women in the goserelin group (RR 0.04, 95% CI 0.01 to 0.30; 1 RCT, 57 women). </p> <p>There was no clear evidence of a difference between the COCP group and the goserelin group for any of the other adverse effects reported including insomnia (RR 0.07, 95% CI 0.00 to 1.15; 1 RCT, 57 women); spotting/irregular bleeding (RR 1.21, 95% CI 0.46 to 3.15; 1 RCT, 57 women); decreased libido (RR 0.69, 95% CI 0.22 to 2.19; 1 RCT, 57 women); vaginal dryness (RR 0.09, 95% CI 0.01 to 1.63; 1 RCT, 57 women); mood changes (RR 1.04, 95% CI 0.34 to 3.19; 1 RCT, 57 women); headache (RR 1.55, 95% CI 0.49 to 4.92; 1 RCT, 57 women); paraesthesia (RR 0.35, 95% CI 0.04 to 3.12; 1 RCT, 57 women); breast tenderness (RR 1.73, 95% CI 0.45 to 6.55; 1 RCT, 57 women); weight gain (RR 2.07, 95% CI 0.41 to 10.43; 1 RCT, 57 women); peripheral oedema (RR 1.04, 95% CI 0.07 to 15.77; 1 RCT, 57 women); joint pain (RR 0.34, 95% CI 0.01 to 8.12; 1 RCT, 57 women) (<a href="./references#CD001019-fig-0023" title="">Analysis 2.9</a>). </p> </section> <section id="CD001019-sec-0128"> <h6 class="title">2.11. Adverse effects persisting after treatment</h6> <p>We found no data on adverse effects persisting after treatment.</p> </section> <section id="CD001019-sec-0129"> <h6 class="title">2.12. Economic evaluations</h6> <p>We found no data on economic evaluations.</p> </section> </section> </section> <section id="CD001019-sec-0130"> <h4 class="title">3. Combined oral contraceptive pill versus conservative surgical treatment</h4> <p>We found no studies comparing COCP versus conservative surgical treatment.</p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD001019-sec-0131" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD001019-sec-0131"></div> <p>Endometriosis is a recurring disease and medical therapy should be viewed as symptom control rather than a cure. At present the use of GnRH analogues is limited to six months because of associated bone loss. The duration of other medical treatments is also limited to six months in the first instance because of unwanted metabolic effects. The OCP has the great advantage that it can be taken for prolonged periods provided it is not contraindicated. Although serious adverse effects, such as thromboembolic episodes, may occur with treatment, the risk is estimated to be only 7/10,000 to 10/10,000 women per year (<a href="./references#CD001019-bbs2-0032" title="BatesonD , ButcherBE , DonovanC , FarrellL , KovacsG , MezziniT , et al. Risk of venous thromboembolism in women taking the combined oral contraceptive: a systematic review and meta‐analysis. Australian Family Physician2016;45(1‐2):59‐64. ">Bateson 2016</a>), the highest risk being within the first year of use. The OCP is widely used by many women long term and risks are well known and accepted by doctors and women. </p> <section id="CD001019-sec-0132"> <h3 class="title" id="CD001019-sec-0132">Summary of main results</h3> <p>Two trials including 354 women compared the COCP with placebo. The COCP was associated with an improvement in self‐reported pain (dysmenorrhoea) at the end of treatment. There were also improvements in cyclical non‐menstrual pain, dyspareunia and dyschezia. Women in the COCP group were more likely to report being very highly or highly satisfied compared with placebo. Spotting, irregular bleeding or menorrhagia, and nausea were more commonly associated with the COCP compared with placebo. </p> <p>Three studies compared COCP with another medical treatment. Data suitable for meta‐analysis were only available from one trial that compared the COCP with goserelin (<a href="./references#CD001019-bbs2-0005" title="VercelliniP , TrespidiL , ColomboA , VendolaN , MarchiniM , CrosignaniPG . A gonadotrophin‐releasing hormone agonist versus a low‐dose oral contraceptive for pelvic pain associated with endometriosis. Fertility and Sterility1993;60(1):75‐9. ">Vercellini 1993</a>). There was no clear evidence of a difference between groups for self‐reported measures of dysmenorrhoea pain reduction or non‐menstrual pain reduction. At the end of treatment, COCP was associated with an increase in dyspareunia as reported using a visual analogue scale; however, at six‐month follow‐up this difference was no longer detected. COCP was associated with a reduced risk of hot flushes compared with goserelin and may, therefore, be an alternative option. </p> <p>No studies compared COCP with conservative surgical treatment were identified.</p> </section> <section id="CD001019-sec-0133"> <h3 class="title" id="CD001019-sec-0133">Overall completeness and applicability of evidence</h3> <p>There continues to be surprisingly little literature about the treatment of endometriosis with OCPs despite their apparent widespread use in clinical practice. Our search strategy identified only three studies that could be included in a meta‐analysis from the five overall studies. Therefore, we were unable to comment on most of the comparisons identified for our objectives. There were no data for the comparison of COCP versus conservative surgical treatment. </p> <p>Two trials of 354 women, both conducted in Japan, compared COCP with placebo. The findings are not likely to be generalisable as, due to the limited evidence, we do not know if different formulations of COCP would have different effects. The formulation used in the Japanese studies may not be readily available globally. </p> <p>In the one study of COCP compared with goserelin, the power calculation became invalid as a result of a higher than expected recurrence rate of pain in the goserelin group (77% recurrence rather than the 35% that was used in the power calculation), rendering the study underpowered. Hence, the study may have failed to detect a difference in efficacy between COCP and goserelin. This study, which was conducted in Italy, is also unlikely to be generalisable to other settings. </p> <p>This review focused on the effectiveness of OCPs for treating pain associated with endometriosis. There are other formulations of the combined hormonal contraception such as the transdermal patch, vaginal ring or combined injectable contraceptives that were not covered in this review but should be considered in future updates. </p> </section> <section id="CD001019-sec-0134"> <h3 class="title" id="CD001019-sec-0134">Quality of the evidence</h3> <p>We prepared 'Summary of findings' tables using GRADEpro and Cochrane methods (<a href="./full#CD001019-tbl-0001">summary of findings Table for the main comparison</a>; <a href="./full#CD001019-tbl-0002">summary of findings Table 2</a>). These tables evaluated the overall quality of the body of evidence for the main review outcome (pain associated with endometriosis) for the main review comparison that had data available (COCP versus placebo and COCP versus goserelin). We assessed the quality of the evidence using GRADE criteria (risk of bias, consistency of effect, imprecision, indirectness and publication bias). Two review authors independently judged quality of evidence (high, moderate, low or very low), with disagreements resolved by discussion. Judgements were justified, documented and incorporated into reporting of results for the outcome. </p> <p>We judged the evidence for the comparison of COCP with placebo to be very low quality overall. We judged the evidence for the comparison of COCP with other medical treatment to be low or very low quality overall. </p> <p>One of the main concerns of the two Japanese trials comparing COCP with placebo was that the trials were supported by a pharmaceutical company that participated in the trial design and managed operational aspects of the trial process, including data collection, analysis and writing of the report (<a href="./references#CD001019-bbs2-0003" title="HaradaT , MomoedaM , TaketaniY , HoshiaiH , TerakawaN . Low‐dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo‐controlled, double‐blind, randomized trial. Fertility and Sterility2008;90(5):1583‐88. ">Harada 2008</a>; <a href="./references#CD001019-bbs2-0004" title="HaradaT , KosakaS , EllisenJ , YasudaM , ItoM , MomoedaM . Ethinylestradiol 20 μg/drospireone 3 mg in a flexible extended regiment for the management of endometriosis‐associated pelvic pain: a randomized controlled trial. Fertility and Sterility2017;108(5):798‐805. [DOI: 10.1016/j.fertstert.2017.07.1165] ">Harada 2017</a>). Authors also received payment from the company. </p> </section> <section id="CD001019-sec-0135"> <h3 class="title" id="CD001019-sec-0135">Potential biases in the review process</h3> <p>Potential biases in the review process were minimised by searching published and unpublished literature from a variety of sources with no restrictions on date of publication or language. At least two review authors independently extracted data and conducted the risk of bias assessment. </p> <p>We were unable to judge the potential effect of publication bias, we identified fewer than 10 trials. </p> </section> <section id="CD001019-sec-0136"> <h3 class="title" id="CD001019-sec-0136">Agreements and disagreements with other studies or reviews</h3> <p>Two reviews of available evidence concluded that oral contraceptives were effective for first‐line treatment of pain associated with endometriosis but noted that this was based on limited evidence (<a href="./references#CD001019-bbs2-0029" title="Al‐JefoutM . Brief update on endometriosis treatment. Middle East Fertility Society Journal2011;16(3):167‐74. ">Al‐Jefout 2011</a>; <a href="./references#CD001019-bbs2-0049" title="ZitoG , LuppiS , GioloE , MartinelliM , VenturinI , DiLorenzoG , et al. Medical treatments for endometriosis‐associated pelvic pain. BioMed Research International2014;2014:191967. [DOI: 10.1155/2014/191967] ">Zito 2014</a>). Neither of these reviews identified additional studies that were not identified and included in this review. We had included the most recent study by <a href="./references#CD001019-bbs2-0004" title="HaradaT , KosakaS , EllisenJ , YasudaM , ItoM , MomoedaM . Ethinylestradiol 20 μg/drospireone 3 mg in a flexible extended regiment for the management of endometriosis‐associated pelvic pain: a randomized controlled trial. Fertility and Sterility2017;108(5):798‐805. [DOI: 10.1016/j.fertstert.2017.07.1165] ">Harada 2017</a>. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD001019-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/media/CDSR/CD001019/urn:x-wiley:14651858:media:CD001019:CD001019-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/media/CDSR/CD001019/image_t/tCD001019-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD001019-fig-0001" src="/cdsr/doi/10.1002/14651858.CD001019.pub3/media/CDSR/CD001019/image_n/nCD001019-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/full#CD001019-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/media/CDSR/CD001019/image_n/nCD001019-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001019-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/media/CDSR/CD001019/urn:x-wiley:14651858:media:CD001019:CD001019-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/media/CDSR/CD001019/image_t/tCD001019-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Methodological quality graph: review authors' judgements about each methodological quality item presented as percentages across all included studies." data-id="CD001019-fig-0002" src="/cdsr/doi/10.1002/14651858.CD001019.pub3/media/CDSR/CD001019/image_n/nCD001019-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Methodological quality graph: review authors' judgements about each methodological quality item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/full#CD001019-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/media/CDSR/CD001019/image_n/nCD001019-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001019-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/media/CDSR/CD001019/urn:x-wiley:14651858:media:CD001019:CD001019-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/media/CDSR/CD001019/image_t/tCD001019-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Methodological quality summary: review authors' judgements about each methodological quality item for each included study." data-id="CD001019-fig-0003" src="/cdsr/doi/10.1002/14651858.CD001019.pub3/media/CDSR/CD001019/image_n/nCD001019-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Methodological quality summary: review authors' judgements about each methodological quality item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/full#CD001019-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/media/CDSR/CD001019/image_n/nCD001019-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001019-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/media/CDSR/CD001019/urn:x-wiley:14651858:media:CD001019:CD001019-AFig-FIG04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/media/CDSR/CD001019/image_t/tCD001019-AFig-FIG04.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Combined oral contractive pill (COCP) versus placebo/no treatment, outcome: 1.1 Self‐reported pain (dysmenorrhoea) at end of treatment." data-id="CD001019-fig-0004" src="/cdsr/doi/10.1002/14651858.CD001019.pub3/media/CDSR/CD001019/image_n/nCD001019-AFig-FIG04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Combined oral contractive pill (COCP) versus placebo/no treatment, outcome: 1.1 Self‐reported pain (dysmenorrhoea) at end of treatment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/full#CD001019-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/media/CDSR/CD001019/image_n/nCD001019-AFig-FIG04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001019-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/media/CDSR/CD001019/urn:x-wiley:14651858:media:CD001019:CD001019-AFig-FIG05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/media/CDSR/CD001019/image_t/tCD001019-AFig-FIG05.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 2 Combined oral contractive pill (COCP) versus other medical treatment, outcome: 2.1 Self‐reported pain (dysmenorrhoea) at end of treatment (continuous data)." data-id="CD001019-fig-0005" src="/cdsr/doi/10.1002/14651858.CD001019.pub3/media/CDSR/CD001019/image_n/nCD001019-AFig-FIG05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Forest plot of comparison: 2 Combined oral contractive pill (COCP) versus other medical treatment, outcome: 2.1 Self‐reported pain (dysmenorrhoea) at end of treatment (continuous data). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/full#CD001019-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/media/CDSR/CD001019/image_n/nCD001019-AFig-FIG05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001019-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/media/CDSR/CD001019/urn:x-wiley:14651858:media:CD001019:CD001019-AFig-FIG06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/media/CDSR/CD001019/image_t/tCD001019-AFig-FIG06.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 2 Combined oral contractive pill (COCP) versus other medical treatment, outcome: 2.2 Self‐reported pain (dysmenorrhoea): VAS (dichotomous data)." data-id="CD001019-fig-0006" src="/cdsr/doi/10.1002/14651858.CD001019.pub3/media/CDSR/CD001019/image_n/nCD001019-AFig-FIG06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 6</div> <div class="figure-caption"> <p>Forest plot of comparison: 2 Combined oral contractive pill (COCP) versus other medical treatment, outcome: 2.2 Self‐reported pain (dysmenorrhoea): VAS (dichotomous data). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/full#CD001019-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/media/CDSR/CD001019/image_n/nCD001019-AFig-FIG06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001019-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/media/CDSR/CD001019/urn:x-wiley:14651858:media:CD001019:CD001019-AFig-FIG07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/media/CDSR/CD001019/image_t/tCD001019-AFig-FIG07.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 2 Combined oral contractive pill (COCP) versus other medical treatment, outcome: 2.3 Self‐reported pain (dysmenorrhoea): VRS (dichotomous data)." data-id="CD001019-fig-0007" src="/cdsr/doi/10.1002/14651858.CD001019.pub3/media/CDSR/CD001019/image_n/nCD001019-AFig-FIG07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 7</div> <div class="figure-caption"> <p>Forest plot of comparison: 2 Combined oral contractive pill (COCP) versus other medical treatment, outcome: 2.3 Self‐reported pain (dysmenorrhoea): VRS (dichotomous data). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/full#CD001019-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/media/CDSR/CD001019/image_n/nCD001019-AFig-FIG07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001019-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/media/CDSR/CD001019/urn:x-wiley:14651858:media:CD001019:CD001019-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/media/CDSR/CD001019/image_t/tCD001019-CMP-001-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Combined oral contractive pill (COCP) versus placebo/no treatment, Outcome 1 Self‐reported pain (dysmenorrhoea) at end of treatment." data-id="CD001019-fig-0008" src="/cdsr/doi/10.1002/14651858.CD001019.pub3/media/CDSR/CD001019/image_n/nCD001019-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Combined oral contractive pill (COCP) versus placebo/no treatment, Outcome 1 Self‐reported pain (dysmenorrhoea) at end of treatment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/references#CD001019-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/media/CDSR/CD001019/image_n/nCD001019-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001019-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/media/CDSR/CD001019/urn:x-wiley:14651858:media:CD001019:CD001019-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/media/CDSR/CD001019/image_t/tCD001019-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Combined oral contractive pill (COCP) versus placebo/no treatment, Outcome 2 Cyclical pain (non‐menstrual)." data-id="CD001019-fig-0009" src="/cdsr/doi/10.1002/14651858.CD001019.pub3/media/CDSR/CD001019/image_n/nCD001019-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Combined oral contractive pill (COCP) versus placebo/no treatment, Outcome 2 Cyclical pain (non‐menstrual). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/references#CD001019-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/media/CDSR/CD001019/image_n/nCD001019-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001019-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/media/CDSR/CD001019/urn:x-wiley:14651858:media:CD001019:CD001019-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/media/CDSR/CD001019/image_t/tCD001019-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Combined oral contractive pill (COCP) versus placebo/no treatment, Outcome 3 Dyspareunia." data-id="CD001019-fig-0010" src="/cdsr/doi/10.1002/14651858.CD001019.pub3/media/CDSR/CD001019/image_n/nCD001019-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Combined oral contractive pill (COCP) versus placebo/no treatment, Outcome 3 Dyspareunia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/references#CD001019-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/media/CDSR/CD001019/image_n/nCD001019-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001019-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/media/CDSR/CD001019/urn:x-wiley:14651858:media:CD001019:CD001019-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/media/CDSR/CD001019/image_t/tCD001019-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Combined oral contractive pill (COCP) versus placebo/no treatment, Outcome 4 Dyschezia (pain on defecation)." data-id="CD001019-fig-0011" src="/cdsr/doi/10.1002/14651858.CD001019.pub3/media/CDSR/CD001019/image_n/nCD001019-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Combined oral contractive pill (COCP) versus placebo/no treatment, Outcome 4 Dyschezia (pain on defecation). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/references#CD001019-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/media/CDSR/CD001019/image_n/nCD001019-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001019-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/media/CDSR/CD001019/urn:x-wiley:14651858:media:CD001019:CD001019-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/media/CDSR/CD001019/image_t/tCD001019-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Combined oral contractive pill (COCP) versus placebo/no treatment, Outcome 5 Satisfaction (very highly/highly satisfied)." data-id="CD001019-fig-0012" src="/cdsr/doi/10.1002/14651858.CD001019.pub3/media/CDSR/CD001019/image_n/nCD001019-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Combined oral contractive pill (COCP) versus placebo/no treatment, Outcome 5 Satisfaction (very highly/highly satisfied). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/references#CD001019-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/media/CDSR/CD001019/image_n/nCD001019-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001019-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/media/CDSR/CD001019/urn:x-wiley:14651858:media:CD001019:CD001019-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/media/CDSR/CD001019/image_t/tCD001019-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Combined oral contractive pill (COCP) versus placebo/no treatment, Outcome 6 Withdrawal from treatment." data-id="CD001019-fig-0013" src="/cdsr/doi/10.1002/14651858.CD001019.pub3/media/CDSR/CD001019/image_n/nCD001019-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Combined oral contractive pill (COCP) versus placebo/no treatment, Outcome 6 Withdrawal from treatment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/references#CD001019-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/media/CDSR/CD001019/image_n/nCD001019-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001019-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/media/CDSR/CD001019/urn:x-wiley:14651858:media:CD001019:CD001019-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/media/CDSR/CD001019/image_t/tCD001019-CMP-001-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Combined oral contractive pill (COCP) versus placebo/no treatment, Outcome 7 Adverse effects occurring during treatment." data-id="CD001019-fig-0014" src="/cdsr/doi/10.1002/14651858.CD001019.pub3/media/CDSR/CD001019/image_n/nCD001019-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 Combined oral contractive pill (COCP) versus placebo/no treatment, Outcome 7 Adverse effects occurring during treatment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/references#CD001019-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/media/CDSR/CD001019/image_n/nCD001019-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001019-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/media/CDSR/CD001019/urn:x-wiley:14651858:media:CD001019:CD001019-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/media/CDSR/CD001019/image_t/tCD001019-CMP-002-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Combined oral contractive pill (COCP) versus other medical treatment, Outcome 1 Self‐reported pain (dysmenorrhoea) at end of treatment (continuous data)." data-id="CD001019-fig-0015" src="/cdsr/doi/10.1002/14651858.CD001019.pub3/media/CDSR/CD001019/image_n/nCD001019-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Combined oral contractive pill (COCP) versus other medical treatment, Outcome 1 Self‐reported pain (dysmenorrhoea) at end of treatment (continuous data). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/references#CD001019-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/media/CDSR/CD001019/image_n/nCD001019-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001019-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/media/CDSR/CD001019/urn:x-wiley:14651858:media:CD001019:CD001019-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/media/CDSR/CD001019/image_t/tCD001019-CMP-002-02.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Combined oral contractive pill (COCP) versus other medical treatment, Outcome 2 Self‐reported pain (dysmenorrhoea): VAS (dichotomous data)." data-id="CD001019-fig-0016" src="/cdsr/doi/10.1002/14651858.CD001019.pub3/media/CDSR/CD001019/image_n/nCD001019-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Combined oral contractive pill (COCP) versus other medical treatment, Outcome 2 Self‐reported pain (dysmenorrhoea): VAS (dichotomous data). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/references#CD001019-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/media/CDSR/CD001019/image_n/nCD001019-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001019-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/media/CDSR/CD001019/urn:x-wiley:14651858:media:CD001019:CD001019-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/media/CDSR/CD001019/image_t/tCD001019-CMP-002-03.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Combined oral contractive pill (COCP) versus other medical treatment, Outcome 3 Self‐reported pain (dysmenorrhoea): VRS (dichotomous data)." data-id="CD001019-fig-0017" src="/cdsr/doi/10.1002/14651858.CD001019.pub3/media/CDSR/CD001019/image_n/nCD001019-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 Combined oral contractive pill (COCP) versus other medical treatment, Outcome 3 Self‐reported pain (dysmenorrhoea): VRS (dichotomous data). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/references#CD001019-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/media/CDSR/CD001019/image_n/nCD001019-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001019-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/media/CDSR/CD001019/urn:x-wiley:14651858:media:CD001019:CD001019-CMP-002-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/media/CDSR/CD001019/image_t/tCD001019-CMP-002-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Combined oral contractive pill (COCP) versus other medical treatment, Outcome 4 Cyclical pain (non‐menstrual pain) (continuous data)." data-id="CD001019-fig-0018" src="/cdsr/doi/10.1002/14651858.CD001019.pub3/media/CDSR/CD001019/image_n/nCD001019-CMP-002-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2 Combined oral contractive pill (COCP) versus other medical treatment, Outcome 4 Cyclical pain (non‐menstrual pain) (continuous data). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/references#CD001019-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/media/CDSR/CD001019/image_n/nCD001019-CMP-002-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001019-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/media/CDSR/CD001019/urn:x-wiley:14651858:media:CD001019:CD001019-CMP-002-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/media/CDSR/CD001019/image_t/tCD001019-CMP-002-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Combined oral contractive pill (COCP) versus other medical treatment, Outcome 5 Cyclical pain (non‐menstrual pain) (dichotomous data)." data-id="CD001019-fig-0019" src="/cdsr/doi/10.1002/14651858.CD001019.pub3/media/CDSR/CD001019/image_n/nCD001019-CMP-002-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2 Combined oral contractive pill (COCP) versus other medical treatment, Outcome 5 Cyclical pain (non‐menstrual pain) (dichotomous data). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/references#CD001019-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/media/CDSR/CD001019/image_n/nCD001019-CMP-002-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001019-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/media/CDSR/CD001019/urn:x-wiley:14651858:media:CD001019:CD001019-CMP-002-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/media/CDSR/CD001019/image_t/tCD001019-CMP-002-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Combined oral contractive pill (COCP) versus other medical treatment, Outcome 6 Dyspareunia (continuous data)." data-id="CD001019-fig-0020" src="/cdsr/doi/10.1002/14651858.CD001019.pub3/media/CDSR/CD001019/image_n/nCD001019-CMP-002-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.6</div> <div class="figure-caption"> <p>Comparison 2 Combined oral contractive pill (COCP) versus other medical treatment, Outcome 6 Dyspareunia (continuous data). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/references#CD001019-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/media/CDSR/CD001019/image_n/nCD001019-CMP-002-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001019-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/media/CDSR/CD001019/urn:x-wiley:14651858:media:CD001019:CD001019-CMP-002-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/media/CDSR/CD001019/image_t/tCD001019-CMP-002-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Combined oral contractive pill (COCP) versus other medical treatment, Outcome 7 Dyspareunia (dichotomous data)." data-id="CD001019-fig-0021" src="/cdsr/doi/10.1002/14651858.CD001019.pub3/media/CDSR/CD001019/image_n/nCD001019-CMP-002-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.7</div> <div class="figure-caption"> <p>Comparison 2 Combined oral contractive pill (COCP) versus other medical treatment, Outcome 7 Dyspareunia (dichotomous data). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/references#CD001019-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/media/CDSR/CD001019/image_n/nCD001019-CMP-002-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001019-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/media/CDSR/CD001019/urn:x-wiley:14651858:media:CD001019:CD001019-CMP-002-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/media/CDSR/CD001019/image_t/tCD001019-CMP-002-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Combined oral contractive pill (COCP) versus other medical treatment, Outcome 8 Withdrawal from treatment." data-id="CD001019-fig-0022" src="/cdsr/doi/10.1002/14651858.CD001019.pub3/media/CDSR/CD001019/image_n/nCD001019-CMP-002-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.8</div> <div class="figure-caption"> <p>Comparison 2 Combined oral contractive pill (COCP) versus other medical treatment, Outcome 8 Withdrawal from treatment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/references#CD001019-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/media/CDSR/CD001019/image_n/nCD001019-CMP-002-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001019-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/media/CDSR/CD001019/urn:x-wiley:14651858:media:CD001019:CD001019-CMP-002-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/media/CDSR/CD001019/image_t/tCD001019-CMP-002-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Combined oral contractive pill (COCP) versus other medical treatment, Outcome 9 Adverse effects." data-id="CD001019-fig-0023" src="/cdsr/doi/10.1002/14651858.CD001019.pub3/media/CDSR/CD001019/image_n/nCD001019-CMP-002-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.9</div> <div class="figure-caption"> <p>Comparison 2 Combined oral contractive pill (COCP) versus other medical treatment, Outcome 9 Adverse effects. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/references#CD001019-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/media/CDSR/CD001019/image_n/nCD001019-CMP-002-09.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD001019-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Combined oral contraceptive pill compared to placebo or no treatment for pain associated with endometriosis</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Combined oral contraceptive pill (COCP) compared to placebo/no treatment for pain associated with endometriosis</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> women with endometriosis<br/> <b>Setting:</b> Japan<br/> <b>Intervention:</b> COCP<br/> <b>Comparison:</b> placebo </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with placebo/no treatment</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with COCP</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Self‐reported pain (dysmenorrhoea) at the end of treatment: dysmenorrhoea VRS</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean self‐reported pain (dysmenorrhoea) at the end of treatment: Dysmenorrhoea VRS was 3.7 </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 1.3 lower<br/> (1.84 lower to 0.76 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>96<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>Very low</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>VRS ranged from 0 to 3.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Self‐reported pain (dysmenorrhoea) at the end of treatment: dysmenorrhoea VAS</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean self‐reported pain (dysmenorrhoea) at the end of treatment: Dysmenorrhoea VAS was 46.2 </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 23.68 lower<br/> (28.75 lower to 18.62 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>327<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>Very low</b><sup>2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No details provided for the VAS.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Self‐reported pain: menstrual pain reduction from baseline to end of treatment</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean menstrual pain (reduction from baseline to end of treatment) was 3.00</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>MD 2.10 lower (1.38 lower to 2.82 lower)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>169</p> <p>(1 RCT)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>Very low</b><sup>1,2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Used a VAS from 0 to 10 where 10 was extreme pain.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>COCP:</b> combined oral contraceptive pill; <b>MD:</b> mean difference; <b>RCT:</b> randomised controlled trial; <b>VAS:</b> visual analogue scale; <b>VRS:</b> verbal rating scale. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate quality:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low quality:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low quality:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Imprecision: evidence was based on a single small trial; downgraded one level. </p> <p><sup>2</sup>Risk of bias: trial judged to be at high risk of bias; downgraded two levels. </p> <p><sup>3</sup>Imprecision: evidence based on a single trial including 96 women; wide confidence intervals; downgraded two levels. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Combined oral contraceptive pill compared to placebo or no treatment for pain associated with endometriosis</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/full#CD001019-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD001019-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Combined oral contraceptive pill compared to other medical treatment for pain associated with endometriosis</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Combined oral contraceptive pill (COCP) compared to other medical treatment for pain associated with endometriosis</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> women with endometriosis<br/> <b>Setting:</b> Italy<br/> <b>Intervention:</b> COCP<br/> <b>Comparison:</b> other medical treatment (goserelin) </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with other medical treatment</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with COCP</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Self‐reported pain (dysmenorrhoea) at the end of treatment (continuous data): dysmenorrhoea at 6 months' follow‐up: VAS</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean self‐reported pain (dysmenorrhoea) at the end of treatment (continuous data): dysmenorrhoea at 6 months' follow‐up was 7.5 </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 0.1 lower<br/> (1.28 lower to 1.08 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>Very low</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>VAS ranged from 1 to 10.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Self‐reported pain (dysmenorrhoea) at the end of treatment (continuous data): dysmenorrhoea at 6 months' follow‐up: VRS</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean self‐reported pain (dysmenorrhoea) at the end of treatment (continuous data): dysmenorrhoea at 6 months' follow‐up was 4.8 </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 0.1 lower<br/> (0.99 lower to 0.79 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>Very low</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>VRS ranged from 0 to 3.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Self‐reported pain (dysmenorrhoea) (dichotomous data): reduction of pain to zero at 6 months' follow‐up: VAS</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>38 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>14 per 1000<br/> (1 to 324) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.36<br/> (0.02 to 8.43) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>Very low</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>VAS ranged from 1 to 10.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Self‐reported pain (dysmenorrhoea) (dichotomous data) ‐ reduction of pain to zero at 6 months' follow‐up: VRS</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>1000 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>1000 per 1000<br/> (930 to 1000) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 1.00<br/> (0.93 to 1.08) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>49<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low</b><sup>1,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>VRS ranged from 0 to 3.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>COCP:</b> combined oral contraceptive pill; <b>MD:</b> mean difference; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio; <b>VAS:</b> visual analogue scale; <b>VRS:</b> verbal rating scale. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate quality:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low quality:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low quality:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Risk of bias: no blinding and randomisation and allocation concealment unclear; downgraded one level. </p> <p><sup>2</sup>Imprecision: evidence from a single small trial including 50 women; wide confidence intervals crossing the line of no effect; downgraded two levels. </p> <p><sup>3</sup>Imprecision: evidence from a single small trial reporting data on 49 women; downgraded one level. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Combined oral contraceptive pill compared to other medical treatment for pain associated with endometriosis</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/full#CD001019-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001019-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Combined oral contractive pill (COCP) versus placebo/no treatment</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Self‐reported pain (dysmenorrhoea) at end of treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Dysmenorrhoea at end of treatment: verbal rating scale (VRS)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>96</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.30 [‐1.84, ‐0.76]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Dysmenorrhoea at end of treatment: visual analogue scale (VAS)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>327</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐23.68 [‐28.75, ‐18.62]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Menstrual pain reduction from baseline to end of treatment: VAS)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>169</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.1 [1.38, 2.82]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Cyclical pain (non‐menstrual) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Non‐menstrual pain at end of treatment: VRS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>96</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.10 [‐0.48, 0.68]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Non‐menstrual pain at end of treatment: VAS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>96</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.90 [‐11.72, 7.92]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 Non‐menstrual pain reduction from baseline to end of treatment: VAS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>212</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.30, 1.70]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Dyspareunia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>89</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.4 [0.46, 2.34]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Dyschezia (pain on defecation) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>231</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.2 [0.56, 1.84]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Satisfaction (very highly/highly satisfied) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>258</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.24 [2.44, 7.37]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Withdrawal from treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>354</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.34 [0.83, 2.18]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Adverse effects occurring during treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 Pregnancy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>96</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.88 [0.12, 68.98]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 Spotting/irregular bleeding/menorrhagia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>354</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.44 [1.44, 4.15]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.3 Nausea</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>354</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.14 [1.79, 9.54]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.4 Any treatment‐associated adverse effect</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>258</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.17 [1.00, 1.36]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Combined oral contractive pill (COCP) versus placebo/no treatment</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/references#CD001019-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001019-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Combined oral contractive pill (COCP) versus other medical treatment</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Self‐reported pain (dysmenorrhoea) at end of treatment (continuous data) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Dysmenorrhoea at 6 months' follow‐up: visual analogue scale (VAS)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.10 [‐1.28, 1.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Dysmenorrhoea at 6 months' follow‐up: verbal rating scale (VRS)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.10 [‐0.99, 0.79]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Self‐reported pain (dysmenorrhoea): VAS (dichotomous data) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Reduction of pain to mild or zero at 6 months' follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.32, 2.58]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Reduction of pain to zero at 6 months' follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.36 [0.02, 8.43]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Self‐reported pain (dysmenorrhoea): VRS (dichotomous data) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Reduction of pain to mild or zero at 6 months' follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.70, 1.28]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Reduction of pain to zero at 6 months' follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.93, 1.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Cyclical pain (non‐menstrual pain) (continuous data) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Non‐menstrual pain at end of treatment: VAS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.20 [‐1.51, 1.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Non‐menstrual pain at end of treatment: VRS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.40 [‐0.51, 1.31]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3 Non‐menstrual pain at 6 months' follow‐up: VAS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.30 [‐1.85, 1.25]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.4 Non‐menstrual pain at 6 months' follow‐up: VRS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [‐1.08, 1.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Cyclical pain (non‐menstrual pain) (dichotomous data) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Reduction of pain to mild or zero at end of treatment: VAS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.81, 1.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Reduction of pain to zero at end of treatment: VAS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.51, 1.89]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.3 Reduction of pain to mild or zero at end of treatment: VRS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.84, 1.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.4 Reduction to zero at end of treatment: VRS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.51, 1.89]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.5 Reduction of pain to mild or zero at 6 months' follow‐up: VAS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.14 [0.85, 1.53]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.6 Reduction of pain to zero at 6 months' follow‐up: VAS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.87 [0.26, 2.85]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.7 Reduction of pain to mild or zero at 6 months' follow‐up: VRS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.63, 1.32]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.8 Reduction of pain to zero at 6 months' follow‐up: VRS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.87 [0.26, 2.85]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Dyspareunia (continuous data) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Dyspareunia at end of treatment: VAS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>43</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.80 [0.18, 3.42]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 Dyspareunia at end of treatment: VRS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>43</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.10 [‐0.41, 0.61]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.3 Dyspareunia at 6 months' follow‐up: VAS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>43</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.40 [‐1.30, 2.10]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.4 Dyspareunia at 6 months' follow‐up: VRS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>43</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.10 [‐0.47, 0.67]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Dyspareunia (dichotomous data) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 Reduction of pain to mild or zero at end of treatment: VAS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>43</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.73 [0.53, 1.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 Reduction of pain to zero at end of treatment: VAS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>43</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.52 [0.19, 1.48]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.3 Reduction of pain to mild or zero at end of treatment: VRS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.56, 1.65]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.4 Reduction of pain to zero at end of treatment: VRS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>38</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.35 [0.99, 1.84]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.5 Reduction of pain to mild or zero at 6 months' follow‐up: VAS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>43</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.62, 1.78]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.6 Reduction of pain to zero at 6 months' follow‐up: VAS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>43</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.70 [0.13, 3.77]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.7 Reduction of pain to mild or zero at 6 months' follow‐up: VRS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>43</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.55, 1.68]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.8 Reduction of pain to zero at 6 months' follow‐up: VRS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>43</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.70 [0.13, 3.77]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Withdrawal from treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>57</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.38 [0.34, 5.62]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Adverse effects <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1 Hot flushes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>57</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.04 [0.01, 0.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.2 Insomnia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>57</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.07 [0.00, 1.15]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.3 Spotting/irregular bleeding</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>57</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.21 [0.46, 3.15]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.4 Decreased libido</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>57</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.69 [0.22, 2.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.5 Vaginal dryness</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>57</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.09 [0.01, 1.63]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.6 Mood change</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>57</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.04 [0.34, 3.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.7 Headache</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>57</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.55 [0.49, 4.92]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.8 Paraesthesia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>57</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.35 [0.04, 3.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.9 Breast tenderness</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>57</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.73 [0.45, 6.55]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.10 Weight gain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>57</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.07 [0.41, 10.43]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.11 Peripheral oedema</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>57</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.04 [0.07, 15.77]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.12 Joint pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>57</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.34 [0.01, 8.12]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Combined oral contractive pill (COCP) versus other medical treatment</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001019.pub3/references#CD001019-tbl-0004">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD001019.pub3&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD001019-note-0007">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD001019-note-0010">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD001019-note-0006">Français</a> </li> <li class="section-language"> <a class="" href="ja#CD001019-note-0004">日本語</a> </li> <li class="section-language"> <a class="" href="ms#CD001019-note-0009">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pl#CD001019-note-0005">Polski</a> </li> <li class="section-language"> <a class="" href="ro#CD001019-note-0008">Română</a> </li> <li class="section-language"> <a class="" href="ru#CD001019-note-0002">Русский</a> </li> <li class="section-language"> <a class="" href="th#CD001019-note-0003">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD001019-note-0001">简体中文</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD001019-note-0014">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738735355000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738735355000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001019\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD001019\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001019\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD001019\x2epub3"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001019\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD001019\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001019\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD001019\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001019\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD001019\x2epub3"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001019\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD001019\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001019\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD001019\x2epub3"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001019\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD001019\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001019\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD001019\x2epub3"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=loVWuZlx&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD001019.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD001019.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD001019.pub3/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD001019.pub3/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD001019.pub3%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740719873451"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD001019.pub3/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740719873455"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD001019.pub3/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918df3629a2e937f',t:'MTc0MDcxOTg3My4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 